<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="jnci"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3274508/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274508/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="JNCI Journal of the National Cancer Institute"><meta name="citation_title" content="Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups"><meta name="citation_authors" content="Kevin Y. Urayama, Ruth F. Jarrett, Henrik Hjalgrim, Arjan Diepstra, Yoichiro Kamatani, Amelie Chabrier, Valerie Gaborieau, Anne Boland, Alexandra Nieters, Nikolaus Becker, Lenka Foretova, Yolanda Benavente, Marc Maynadié, Anthony Staines, Lesley Shield, Annette Lake, Dorothy Montgomery, Malcolm Taylor, Karin Ekström Smedby, Rose-Marie Amini, Hans-Olov Adami, Bengt Glimelius, Bjarke Feenstra, Ilja M. Nolte, Lydia Visser, Gustaaf W. van Imhoff, Tracy Lightfoot, Pierluigi Cocco, Lambertus Kiemeney, Sita H. Vermeulen, Ivana Holcatova, Lars Vatten, Gary J. Macfarlane, Peter Thomson, David I. Conway, Simone Benhamou, Antonio Agudo, Claire M. Healy, Kim Overvad, Anne Tjønneland, Beatrice Melin, Federico Canzian, Kay-Tee Khaw, Ruth C. Travis, Petra H. M. Peeters, Carlos A. González, José Ramón Quirós, María-José Sánchez, José María Huerta, Eva Ardanaz, Miren Dorronsoro, Françoise Clavel-Chapelon, H. Bas Bueno-de-Mesquita, Elio Riboli, Eve Roman, Paolo Boffetta, Silvia de Sanjosé, Diana Zelenika, Mads Melbye, Anke van den Berg, Mark Lathrop, Paul Brennan, James D. McKay"><meta name="citation_date" content="8 February 2012"><meta name="citation_issue" content="3"><meta name="citation_volume" content="104"><meta name="citation_firstpage" content="240"><meta name="citation_doi" content="10.1093/jnci/djr516"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3274508/?report=abstract"><meta name="citation_pmid" content="22286212"><meta name="DC.Title" content="Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Oxford University Press"><meta name="DC.Contributor" content="Kevin Y. Urayama"><meta name="DC.Contributor" content="Ruth F. Jarrett"><meta name="DC.Contributor" content="Henrik Hjalgrim"><meta name="DC.Contributor" content="Arjan Diepstra"><meta name="DC.Contributor" content="Yoichiro Kamatani"><meta name="DC.Contributor" content="Amelie Chabrier"><meta name="DC.Contributor" content="Valerie Gaborieau"><meta name="DC.Contributor" content="Anne Boland"><meta name="DC.Contributor" content="Alexandra Nieters"><meta name="DC.Contributor" content="Nikolaus Becker"><meta name="DC.Contributor" content="Lenka Foretova"><meta name="DC.Contributor" content="Yolanda Benavente"><meta name="DC.Contributor" content="Marc Maynadié"><meta name="DC.Contributor" content="Anthony Staines"><meta name="DC.Contributor" content="Lesley Shield"><meta name="DC.Contributor" content="Annette Lake"><meta name="DC.Contributor" content="Dorothy Montgomery"><meta name="DC.Contributor" content="Malcolm Taylor"><meta name="DC.Contributor" content="Karin Ekström Smedby"><meta name="DC.Contributor" content="Rose-Marie Amini"><meta name="DC.Contributor" content="Hans-Olov Adami"><meta name="DC.Contributor" content="Bengt Glimelius"><meta name="DC.Contributor" content="Bjarke Feenstra"><meta name="DC.Contributor" content="Ilja M. Nolte"><meta name="DC.Contributor" content="Lydia Visser"><meta name="DC.Contributor" content="Gustaaf W. van Imhoff"><meta name="DC.Contributor" content="Tracy Lightfoot"><meta name="DC.Contributor" content="Pierluigi Cocco"><meta name="DC.Contributor" content="Lambertus Kiemeney"><meta name="DC.Contributor" content="Sita H. Vermeulen"><meta name="DC.Contributor" content="Ivana Holcatova"><meta name="DC.Contributor" content="Lars Vatten"><meta name="DC.Contributor" content="Gary J. Macfarlane"><meta name="DC.Contributor" content="Peter Thomson"><meta name="DC.Contributor" content="David I. Conway"><meta name="DC.Contributor" content="Simone Benhamou"><meta name="DC.Contributor" content="Antonio Agudo"><meta name="DC.Contributor" content="Claire M. Healy"><meta name="DC.Contributor" content="Kim Overvad"><meta name="DC.Contributor" content="Anne Tjønneland"><meta name="DC.Contributor" content="Beatrice Melin"><meta name="DC.Contributor" content="Federico Canzian"><meta name="DC.Contributor" content="Kay-Tee Khaw"><meta name="DC.Contributor" content="Ruth C. Travis"><meta name="DC.Contributor" content="Petra H. M. Peeters"><meta name="DC.Contributor" content="Carlos A. González"><meta name="DC.Contributor" content="José Ramón Quirós"><meta name="DC.Contributor" content="María-José Sánchez"><meta name="DC.Contributor" content="José María Huerta"><meta name="DC.Contributor" content="Eva Ardanaz"><meta name="DC.Contributor" content="Miren Dorronsoro"><meta name="DC.Contributor" content="Françoise Clavel-Chapelon"><meta name="DC.Contributor" content="H. Bas Bueno-de-Mesquita"><meta name="DC.Contributor" content="Elio Riboli"><meta name="DC.Contributor" content="Eve Roman"><meta name="DC.Contributor" content="Paolo Boffetta"><meta name="DC.Contributor" content="Silvia de Sanjosé"><meta name="DC.Contributor" content="Diana Zelenika"><meta name="DC.Contributor" content="Mads Melbye"><meta name="DC.Contributor" content="Anke van den Berg"><meta name="DC.Contributor" content="Mark Lathrop"><meta name="DC.Contributor" content="Paul Brennan"><meta name="DC.Contributor" content="James D. McKay"><meta name="DC.Date" content="2012 Feb 8"><meta name="DC.Identifier" content="10.1093/jnci/djr516"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups"><meta property="og:type" content="article"><meta property="og:description" content="Accumulating evidence suggests that risk factors for classical Hodgkin lymphoma (cHL) differ by tumor Epstein–Barr virus (EBV) status. This potential etiological heterogeneity is not recognized in current disease classification.We conducted a ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274508/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jnci.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3274508/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3274508/pdf/djr516.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE88A7D9DD531ED100000000086E05BE.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3274508%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22J Natl Cancer Inst%22[journal]" class="navlink">J Natl Cancer Inst</a></li><li class="accid">PMC3274508</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jnci.png" alt="Logo of jnci" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://academic.oup.com/jnci" target="pmc_ext" ref="reftype=publisher&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">J Natl Cancer Inst</a></span>. 2012 Feb 8; 104(3): 240–253. </span></div><div><span class="fm-vol-iss-date">Published online 2012 Jan 27. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1093%2Fjnci%2Fdjr516" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1093/jnci/djr516</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3274508</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/22286212">22286212</a></div></div></div></div><h1 class="content-title">Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Urayama%20KY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Kevin Y. Urayama</a>, <a href="/pubmed/?term=Jarrett%20RF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Ruth F. Jarrett</a>, <a href="/pubmed/?term=Hjalgrim%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Henrik Hjalgrim</a>, <a href="/pubmed/?term=Diepstra%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Arjan Diepstra</a>, <a href="/pubmed/?term=Kamatani%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Yoichiro Kamatani</a>, <a href="/pubmed/?term=Chabrier%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Amelie Chabrier</a>, <a href="/pubmed/?term=Gaborieau%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Valerie Gaborieau</a>, <a href="/pubmed/?term=Boland%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Anne Boland</a>, <a href="/pubmed/?term=Nieters%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Alexandra Nieters</a>, <a href="/pubmed/?term=Becker%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Nikolaus Becker</a>, <a href="/pubmed/?term=Foretova%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Lenka Foretova</a>, <a href="/pubmed/?term=Benavente%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Yolanda Benavente</a>, <a href="/pubmed/?term=Maynadi%26%23x000e9%3B%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Marc Maynadié</a>, <a href="/pubmed/?term=Staines%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Anthony Staines</a>, <a href="/pubmed/?term=Shield%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Lesley Shield</a>, <a href="/pubmed/?term=Lake%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Annette Lake</a>, <a href="/pubmed/?term=Montgomery%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Dorothy Montgomery</a>, <a href="/pubmed/?term=Taylor%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Malcolm Taylor</a>, <a href="/pubmed/?term=Smedby%20KE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Karin Ekström Smedby</a>, <a href="/pubmed/?term=Amini%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Rose-Marie Amini</a>, <a href="/pubmed/?term=Adami%20HO%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Hans-Olov Adami</a>, <a href="/pubmed/?term=Glimelius%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Bengt Glimelius</a>, <a href="/pubmed/?term=Feenstra%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Bjarke Feenstra</a>, <a href="/pubmed/?term=Nolte%20IM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Ilja M. Nolte</a>, <a href="/pubmed/?term=Visser%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Lydia Visser</a>, <a href="/pubmed/?term=van%20Imhoff%20GW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Gustaaf W. van Imhoff</a>, <a href="/pubmed/?term=Lightfoot%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Tracy Lightfoot</a>, <a href="/pubmed/?term=Cocco%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Pierluigi Cocco</a>, <a href="/pubmed/?term=Kiemeney%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Lambertus Kiemeney</a>, <a href="/pubmed/?term=Vermeulen%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Sita H. Vermeulen</a>, <a href="/pubmed/?term=Holcatova%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Ivana Holcatova</a>, <a href="/pubmed/?term=Vatten%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Lars Vatten</a>, <a href="/pubmed/?term=Macfarlane%20GJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Gary J. Macfarlane</a>, <a href="/pubmed/?term=Thomson%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Peter Thomson</a>, <a href="/pubmed/?term=Conway%20DI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">David I. Conway</a>, <a href="/pubmed/?term=Benhamou%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Simone Benhamou</a>, <a href="/pubmed/?term=Agudo%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Antonio Agudo</a>, <a href="/pubmed/?term=Healy%20CM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Claire M. Healy</a>, <a href="/pubmed/?term=Overvad%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Kim Overvad</a>, <a href="/pubmed/?term=Tj%26%23x000f8%3Bnneland%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Anne Tjønneland</a>, <a href="/pubmed/?term=Melin%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Beatrice Melin</a>, <a href="/pubmed/?term=Canzian%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Federico Canzian</a>, <a href="/pubmed/?term=Khaw%20KT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Kay-Tee Khaw</a>, <a href="/pubmed/?term=Travis%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Ruth C. Travis</a>, <a href="/pubmed/?term=Peeters%20PH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Petra H. M. Peeters</a>, <a href="/pubmed/?term=Gonz%26%23x000e1%3Blez%20CA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Carlos A. González</a>, <a href="/pubmed/?term=Quir%26%23x000f3%3Bs%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">José Ramón Quirós</a>, <a href="/pubmed/?term=S%26%23x000e1%3Bnchez%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">María-José Sánchez</a>, <a href="/pubmed/?term=Huerta%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">José María Huerta</a>, <a href="/pubmed/?term=Ardanaz%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Eva Ardanaz</a>, <a href="/pubmed/?term=Dorronsoro%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Miren Dorronsoro</a>, <a href="/pubmed/?term=Clavel-Chapelon%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Françoise Clavel-Chapelon</a>, <a href="/pubmed/?term=Bueno-de-Mesquita%20HB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">H. Bas Bueno-de-Mesquita</a>, <a href="/pubmed/?term=Riboli%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Elio Riboli</a>, <a href="/pubmed/?term=Roman%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Eve Roman</a>, <a href="/pubmed/?term=Boffetta%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Paolo Boffetta</a>, <a href="/pubmed/?term=de%20Sanjos%26%23x000e9%3B%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Silvia de Sanjosé</a>, <a href="/pubmed/?term=Zelenika%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Diana Zelenika</a>, <a href="/pubmed/?term=Melbye%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Mads Melbye</a>, <a href="/pubmed/?term=van%20den%20Berg%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Anke van den Berg</a>, <a href="/pubmed/?term=Lathrop%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Mark Lathrop</a>, <a href="/pubmed/?term=Brennan%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">Paul Brennan</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup> and  <a href="/pubmed/?term=McKay%20JD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22286212">James D. McKay</a></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140214673221248_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140214673221248_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140214673221248_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140214673221248_ai" style="display:none"><div class="fm-affl" id="idm140214670485008" lang="en"><strong>Affiliations of authors:</strong> Genetics Section, International Agency for Research on Cancer, Lyon, France (KYU, AC, VG, PBr, JDM); MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK (RFJ, LS, AL, DM); Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark (HH, BF, MMe); Department of Pathology and Medical Biology (AD, LVi, AvdB), Department of Epidemiology (IMN), and Department of Hematology (GWvI), University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands; Fondation Jean Dausset, Centre d’Etude du Polymorphisme Humain (CEPH), Paris, France (YK, ML); Centre National de Génotypage, Institut Génomique, Commissariat à l’énergie Atomique, Evry, France (AB, DZ, ML); Centre of Chronic Immunodeficiency, University Medical Centre Freiburg, Freiburg, Germany (AN); Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany (NB); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (LF); Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Barcelona, Spain (YB, SDS); CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (YB, M-JS, JMH, EA, MD, SDS); Registry of Hematological Malignancies, EA4184, University of Burgundy, University Hospital of Dijon, Dijon, France (MMa); School of Nursing, Dublin City University, Dublin, Ireland (AS); Cancer Immunogenetics Group, School of Cancer Sciences, University of Manchester, St Mary's Hospital, Manchester, UK (MT); Department of Medicine-Solna, Clinical Epidemiology Unit, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden (KES); Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden (R-MA); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (H-OA); Department of Epidemiology, Harvard School of Public Health, Boston, MA (H-OA); Department of Radiology, Oncology, and Radiation Science, Uppsala University, Uppsala, Sweden (BG); Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, UK (TL, ERo); Department of Public Health, Occupational Health Section, University of Cagliari, Cagliari, Italy (PC); Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (LK, SHV); Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic (IH); Department of Public Health, Norwegian University of Science and Technology, Trondheim, Norway (LVa); Epidemiology Group, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK (GJM); Oral &amp; Maxillofacial Surgery, School of Dental Sciences, Newcastle University, Newcastle, UK (PT); Dental School, College of Medical, Veterinary &amp; Life Sciences, University of Glasgow, Glasgow, UK (DIC); Unit of Genetic Variability and Human Diseases, INSERM U946, Paris, France (SB); Unit of Nutrition, Environment and Cancer (IDIBELL, RETICC DR06-0020), Catalan Institute of Oncology (ICO), Barcelona, Spain (AA, CAG); Division of Oral and Maxillofacial Surgery, Oral Medicine and Oral Pathology, Trinity College School of Dental Science, Dublin, Ireland (CMH); Department of Epidemiology and Social Medicine, Aarhus University, Aarhus, Denmark (KO); Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (AT); Department of Radiation Sciences, Oncology, University of Umeå, Umeå, Sweden (BM); Genomic Epidemiology Group, German Cancer Research Center, Heidelberg, Germany (FC); School of Clinical Medicine, University of Cambridge, Cambridge, UK (K-TK); Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK (RCT); Julius Center for Health Sciences and Primary Care, University Medical Center of Utrecht, Utrecht, the Netherlands (PHMP); Public Health Directorate, Asturian Council for Health and Health Care, Asturias, Spain (JRQ); Andalusian School of Public Health, Granada, Spain (M-JS); Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain (JMH); Health Department, Navarra Public Health Institute, Pamplona, Spain (EA); Public Health Division of Gipuzkoa, Basque Regional Health Department, San Sebastian, Spain (MD); EPIC Group Institut Gustave Roussy, INSERM U1018, Villejuif, France (FC-C); Centre for Nutrition and Health, National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands (HBB-d-M); Department of Gastroenterology and Hepatology, University Medical Centre Utrecht (UMCU), Utrecht, the Netherlands (HBB-d-M); School of Public Health, Imperial College, London, UK (ERi); The Tisch Cancer Institute and Institute for Translational Epidemiology, Mount Sinai School of Medicine, New York City, New York (PBo); International Prevention Research Institute, Lyon, France (PBo)</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup>Corresponding author.</div><div id="idm140214672604368"><strong>Correspondence to</strong>: Paul Brennan, PhD, Genetic Epidemiology Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69008, France (e-mail: <a href="mailto:dev@null" data-email="rf.crai@nannerb" class="oemail">rf.crai@nannerb</a>).</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140214673221248_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2011 May 16; Revised 2011 Nov 7; Accepted 2011 Nov 17.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140214673221248_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © The Author 2012. Published by Oxford University Press.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3274508/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">
Supplementary Data
</div>

<div><a href="/pmc/articles/PMC3274508/bin/supp_104_3_240__index.html" data-ga-action="click_feat_suppl">supp_104_3_240__index.html</a><span style="color:gray"> (999 bytes)</span></div><div class="small guid">GUID:&nbsp;C13EDC1B-172B-4B75-9549-F42256EFE0DD</div>
<div><a href="/pmc/articles/PMC3274508/bin/supp_djr516_jnci-JNCI-11-0690-s01.pdf" data-ga-action="click_feat_suppl">supp_djr516_jnci-JNCI-11-0690-s01.pdf</a><span style="color:gray"> (316K)</span></div><div class="small guid">GUID:&nbsp;E99A28AB-F572-4D91-844E-93C107531440</div>
</div></dd></dl></div><div id="idm140214672096880" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140214672096880title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Accumulating evidence suggests that risk factors for classical Hodgkin lymphoma (cHL) differ by tumor Epstein–Barr virus (EBV) status. This potential etiological heterogeneity is not recognized in current disease classification.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">We conducted a genome-wide association study of 1200 cHL patients and 6417 control subjects, with validation in an independent replication series, to identify common genetic variants associated with total cHL and subtypes defined by tumor EBV status. Multiple logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) assuming a log-additive genetic model for the variants. All statistical tests were two-sided.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">Two novel loci associated with total cHL irrespective of EBV status were identified in the major histocompatibility complex region; one resides adjacent to <em>MICB</em> (rs2248462: OR = 0.61, 95% CI = 0.53 to 0.69, <em>P</em> = 1.3 × 10<sup>−13</sup>) and the other at <em>HLA-DRA</em> (rs2395185: OR = 0.56, 95% CI = 0.50 to 0.62, <em>P</em> = 8.3 × 10<sup>−25</sup>) with both results confirmed in an independent replication series. Consistent with previous reports, associations were found between EBV-positive cHL and genetic variants within the class I region (rs2734986, <em>HLA-A</em>: OR = 2.45, 95% CI = 2.00 to 3.00, <em>P</em> = 1.2 × 10<sup>−15</sup>; rs6904029, <em>HCG9</em>: OR = 0.46, 95% CI = 0.36 to 0.59, <em>P</em> = 5.5 × 10<sup>−10</sup>) and between EBV-negative cHL and rs6903608 within the class II region (rs6903608, <em>HLA-DRA</em>: OR = 2.08, 95% CI = 1.84 to 2.35, <em>P</em> = 6.1 × 10<sup>−31</sup>). The association between rs6903608 and EBV-negative cHL was confined to the nodular sclerosis histological subtype. Evidence for an association between EBV-negative cHL and rs20541 (5q31, <em>IL13</em>: OR = 1.53, 95% CI = 1.32 to 1.76, <em>P</em> = 5.4 x 10<sup>−9</sup>), a variant previously linked to psoriasis and asthma, was observed; however, the evidence for replication was less clear. Notably, one additional psoriasis-associated variant, rs27524 (5q15, <em>ERAP1</em>), showed evidence of an association with cHL in the genome-wide association study (OR = 1.21, 95% CI = 1.10 to 1.33, <em>P</em> = 1.5 × 10<sup>−4</sup>) and replication series (<em>P</em> = .03).</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">Overall, these results provide strong evidence that EBV status is an etiologically important classification of cHL and also suggest that some components of the pathological process are common to both EBV-positive and EBV-negative patients.</p></div></div></div><div id="idm140214744313216" class="tsec sec headless whole_rhythm"><div class="boxed-text-box whole_rhythm hide-overflow"><div class="sec"><h3 id="__sec5title">CONTEXT AND CAVEATS</h3><div class="sec"><h4 id="__sec6title">Prior knowledge</h4><p id="__p6" class="p p-first-last">Hodgkin lymphoma (HL) is one of the most common cancers among adolescents and young adults. Epstein–Barr virus (EBV) has been associated with some HL patients who have one of the major forms—classical HL (cHL). Although the relationship between EBV and cHL is not fully understood, it has been hypothesized that genetic factors may be involved.</p></div><div class="sec"><h4 id="__sec7title">Study design</h4><p id="__p7" class="p p-first-last">To determine if EBV status should be considered when classifying the different subtypes of cHL, a genome-wide association study was done using data from a large series of cHL patients for whom EBV status was known. The results were validated in an independent replication study and genetic variants associated with cHL, EBV-positive cHL, and EBV-negative cHL were identified.</p></div><div class="sec"><h4 id="__sec8title">Contributions</h4><p id="__p8" class="p p-first-last">Two variants located in the major histocompatibility complex (MHC) were independently associated with cHL, regardless of EBV status, and were confirmed in the replication series. Two genetic variants within the class I region of the MHC previously identified in reports as having an association with EBV-positive cHL were also observed. One genetic variant in the class II region of the MHC and one variant previously linked to psoriasis and asthma were associated with EBV-negative cHL. These results indicate that although there are some loci associated with cHL, regardless of EBV status, there are also some loci that are heterogeneous in their relationship with cHL EBV subtypes.</p></div><div class="sec"><h4 id="__sec9title">Implication</h4><p id="__p9" class="p p-first-last">EBV status should be included in the classification of cHL.</p></div><div class="sec"><h4 id="__sec10title">Limitations</h4><p id="__p10" class="p p-first">Although this is the largest GWAS of cHL to date, the statistical power of this study may not have been high enough to detect associations involving rare variants or less common cHL subtypes, such as EBV-positive cHL. Also, systematic bias could have been introduced from differences in genotyping between patients and some control subjects.</p><p id="__p11" class="p p-last">From the Editors</p></div></div></div><p></p><p id="__p12">Hodgkin lymphoma (HL) is a malignant condition of B lymphocyte origin and is among the most common cancers in adolescents and young adults (<a href="#bib1" rid="bib1" class=" bibr popnode">1</a>). Current classification broadly divides HL into two major forms that are thought to be distinct clinicopathologic entities: classical HL (cHL), which accounts for about 95% of HL, and the less prevalent nodular lymphocyte–predominant HL (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>). cHL is characterized by the presence of a small number of Hodgkin and Reed–Sternberg (HRS) tumor cells scattered within an admixture of inflammatory cells and is further subdivided into four histological subtypes consisting of nodular sclerosis HL (NSHL), mixed cellularity HL (MCHL), lymphocyte-depleted HL, and lymphocyte-rich HL (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>,<a href="#bib3" rid="bib3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945897">3</a>).</p><p id="__p13">Epstein–Barr virus (EBV) has been etiologically associated with a proportion of cHL patients (<a href="#bib4" rid="bib4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_562000613">4</a>,<a href="#bib5" rid="bib5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945923">5</a>). EBV latent membrane protein (LMP)-1 and/or EBV-encoded small RNAs (EBERs) have been detected in HRS cells in as many as 40% of cHL patients in economically developed countries (<a href="#bib5" rid="bib5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945943">5</a>,<a href="#bib6" rid="bib6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945969">6</a>). The presence of clonal EBV genomes in tumor cells and the known transforming potential of LMP-1 and LMP-2 suggest that EBV plays a direct role in the pathogenesis of cHL. The proportion of EBV-positive cHLs varies with sex, age, ethnicity, and regional economic development. Specifically, EBV-positive cHL is more frequently observed in males, children and older adults, nonwhites, and in less economically developed regions of the world (<a href="#bib7" rid="bib7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945917">7</a>). Compared with the NSHL histological subtype, MCHL is more likely to be EBV positive across all age groups, but particularly for young adults (<a href="#bib7" rid="bib7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945903">7</a>). However, because approximately 60% of cHLs are NSHL (vs about 30% MCHL), the majority of EBV-positive cHLs are of this histological subtype.</p><p id="__p14">A small number of B lymphocytes in most healthy adults are persistently infected with EBV. The factors associated with progression to EBV-related cHL are not fully understood, but growing evidence suggests that it is likely to be influenced by genetic factors (<a href="#bib8" rid="bib8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945902">8</a>,<a href="#bib9" rid="bib9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945895">9</a>). Antiviral immune responses are considered to be essential in the control of EBV-induced lymphomagenesis. Accordingly, a previously reported genetic screening study using 33 microsatellite markers across the major histocompatibility complex (MHC) region, a region densely populated with immunoregulatory genes, identified susceptibility loci within the class I and class III regions that were specifically associated with EBV-positive or EBV-negative cHL (<a href="#bib8" rid="bib8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945947">8</a>). Subsequent evidence has emerged that supports a strong involvement of the highly polymorphic <em>HLA-A</em> locus in EBV-positive cHL in which <em>HLA-A*01</em> confers an approximate twofold increased risk per allele, whereas <em>HLA</em>-<em>A*02</em> was associated with an approximate 40% reduction in risk (<a href="#bib9" rid="bib9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945906">9</a>,<a href="#bib10" rid="bib10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945950">10</a>). Also, a recent genome-wide association study (GWAS) showed an association between cHL and an MHC class II variant, rs6903608, which appeared to be largely confined to the EBV-negative subtype (<a href="#bib11" rid="bib11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_478821574">11</a>).</p><p id="__p15" class="p">Taken together, these previous reports provide a strong indication that cHL is an etiologically heterogeneous disease that may warrant consideration of EBV status as an addition to the current classification of cHL, which does not include EBV. We therefore conducted a GWAS among a large series of EBV-classified cHL patients and control subjects, with an emphasis on incorporating EBV status in the definition of tumor phenotype, to identify common genetic variants involved in the susceptibility to cHL.</p></div><div id="__sec11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec11title">Methods</h2><div id="__sec12" class="sec sec-first"><h3 id="__sec12title">GWAS Samples</h3><p id="__p16" class="p p-first">Genome-wide genotyping was performed on cHL case samples from five European-based HL studies: the EPILYMPH Study, the Scotland and Newcastle Lymphoma Group, the Young Adult Hodgkin’s Disease Case–Control Study, the Scandinavian Lymphoma Etiology Study, and the Northern Dutch Hodgkin Lymphoma Study (<a href="/pmc/articles/PMC3274508/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). Briefly, EPILYMPH is a multicenter case–control study of lymphoma conducted between January 1998 and June 2003 that included patients from centers in six European countries and followed a common core protocol (<a href="#bib12" rid="bib12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945926">12</a>). The Scotland and Newcastle Lymphoma Group includes the Scotland and Newcastle Epidemiological Study of Hodgkin's Disease, which is a case–control study conducted in Scotland and Northern England between January 1993 and July 1997 (<a href="#bib6" rid="bib6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945929">6</a>), and the “local case series,” a prospectively collected series of patients within those regions between January 1992 and March 2008 (<a href="#bib9" rid="bib9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945957">9</a>). The Young Adult Hodgkin’s Disease Case–Control Study is a case–control study of HL in adolescents and young adults (aged 16–24 years) conducted in the United Kingdom in the regions of Yorkshire, Wessex, Southwest Family Health Service Authority areas, and parts of Cumbria and Lancashire between October 1991 and May 1995 (<a href="#bib13" rid="bib13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945940">13</a>). The Scandinavian Lymphoma Etiology Study is a case–control study of lymphomas conducted in Denmark and Sweden between January 1999 and August 2002 (<a href="#bib14" rid="bib14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945946">14</a>), and the Northern Dutch Hodgkin Lymphoma Study comprises a population-based case patient series of HL diagnosed in Northern Netherlands between January 1987 and April 2009 (<a href="#bib8" rid="bib8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945931">8</a>). DNA samples of sufficient quality and quantity for genome-wide genotyping were available for 1238 cHL patients aged 15–80 years (median age = 33 years), as well as 1395 study-specific control subjects representing nine European countries, including the Czech Republic, Denmark, France, Germany, Ireland, the Netherlands, Spain, Sweden, and the United Kingdom. The study protocol was approved by the institutional review boards, regional scientific ethics committees, and/or data protection agencies of all collaborating centers or institutions, and written informed consent was obtained for all participating subjects.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="tbl1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p17">Subjects included in the genome-wide association and replication analyses examining the relationship between genetic variants and classical Hodgkin lymphoma</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140214667304720" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td rowspan="2" colspan="1" valign="bottom">Study name, duration</td><td rowspan="1" colspan="1"></td><td colspan="4" rowspan="1" valign="bottom" align="center">Case patients, No.<sup>*</sup><hr></td><td colspan="2" rowspan="1" valign="bottom" align="center">Control subjects, No.<sup>*</sup><hr></td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">Country</td><td rowspan="1" colspan="1" valign="bottom" align="center">EBV positive</td><td rowspan="1" colspan="1" valign="bottom" align="center">EBV negative</td><td rowspan="1" colspan="1" valign="bottom" align="center">EBV not available</td><td rowspan="1" colspan="1" valign="bottom" align="center">Total</td><td rowspan="1" colspan="1" valign="bottom" align="center">Generic (source)<sup>†</sup></td><td rowspan="1" colspan="1" valign="bottom" align="center">Study specific</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">GWAS</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    Total</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">265</td><td rowspan="1" colspan="1" align="center">668</td><td rowspan="1" colspan="1" align="center">267</td><td rowspan="1" colspan="1" align="center">1200</td><td rowspan="1" colspan="1" align="center">6417</td><td rowspan="1" colspan="1" align="center">1395</td></tr><tr><td rowspan="1" colspan="1">    EPILYMPH Study, 1998–2003</td><td rowspan="1" colspan="1" align="center">France, Germany, Spain, Czech Republic, Ireland</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">11</td><td rowspan="1" colspan="1" align="center">162</td><td rowspan="1" colspan="1" align="center">181</td><td rowspan="1" colspan="1" align="center">863 (ARCAGE, PANSCAN, CE)</td><td rowspan="1" colspan="1" align="center">377</td></tr><tr><td rowspan="1" colspan="1">    Scotland and Newcastle Lymphoma Group, 1992–2008<sup>‡</sup>; Young Adult Hodgkin Case–Control Study, 1991–1995</td><td rowspan="1" colspan="1" align="center">United Kingdom</td><td rowspan="1" colspan="1" align="center">106</td><td rowspan="1" colspan="1" align="center">240</td><td rowspan="1" colspan="1" align="center">45</td><td rowspan="1" colspan="1" align="center">391</td><td rowspan="1" colspan="1" align="center">3172 (ARCAGE, PANSCAN, WTCCC)</td><td rowspan="1" colspan="1" align="center">348</td></tr><tr><td rowspan="1" colspan="1">    Scandinavian Lymphoma Etiology Study, 1999–2002</td><td rowspan="1" colspan="1" align="center">Denmark, Sweden</td><td rowspan="1" colspan="1" align="center">83</td><td rowspan="1" colspan="1" align="center">211</td><td rowspan="1" colspan="1" align="center">47</td><td rowspan="1" colspan="1" align="center">341</td><td rowspan="1" colspan="1" align="center">578 (PANSCAN, HUNT2/Tromsø)</td><td rowspan="1" colspan="1" align="center">670</td></tr><tr><td rowspan="1" colspan="1">    Northern Dutch Hodgkin Lymphoma Study, 1987–2009</td><td rowspan="1" colspan="1" align="center">The Netherlands</td><td rowspan="1" colspan="1" align="center">68</td><td rowspan="1" colspan="1" align="center">206</td><td rowspan="1" colspan="1" align="center">13</td><td rowspan="1" colspan="1" align="center">287</td><td rowspan="1" colspan="1" align="center">1804 (NBS, PANSCAN)</td><td rowspan="1" colspan="1" align="center">0</td></tr><tr><td rowspan="1" colspan="1">Replication</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    Total</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">131</td><td rowspan="1" colspan="1" align="center">291</td><td rowspan="1" colspan="1" align="center">141</td><td rowspan="1" colspan="1" align="center">563</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">613</td></tr><tr><td rowspan="1" colspan="1">    EPILYMPH Study, 1998−2003</td><td rowspan="1" colspan="1" align="center">France, Germany, Spain, Czech Republic, Ireland, Italy</td><td rowspan="1" colspan="1" align="center">6</td><td rowspan="1" colspan="1" align="center">11</td><td rowspan="1" colspan="1" align="center">47</td><td rowspan="1" colspan="1" align="center">64</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">396</td></tr><tr><td rowspan="1" colspan="1">    Scotland and Newcastle Lymphoma Group, 1992–2008<sup>‡</sup></td><td rowspan="1" colspan="1" align="center">United Kingdom</td><td rowspan="1" colspan="1" align="center">81</td><td rowspan="1" colspan="1" align="center">167</td><td rowspan="1" colspan="1" align="center">34</td><td rowspan="1" colspan="1" align="center">282</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">32</td></tr><tr><td rowspan="1" colspan="1">    Young Adult Hodgkin Case–Control Study, 1991–1995</td><td rowspan="1" colspan="1" align="center">United Kingdom</td><td rowspan="1" colspan="1" align="center">11</td><td rowspan="1" colspan="1" align="center">43</td><td rowspan="1" colspan="1" align="center">4</td><td rowspan="1" colspan="1" align="center">58</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">10</td></tr><tr><td rowspan="1" colspan="1">    Epidemiology and Genetics Lymphoma Case–Control Study, 1998–2003</td><td rowspan="1" colspan="1" align="center">United Kingdom</td><td rowspan="1" colspan="1" align="center">33</td><td rowspan="1" colspan="1" align="center">70</td><td rowspan="1" colspan="1" align="center">56</td><td rowspan="1" colspan="1" align="center">159</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">175</td></tr></tbody></table></div><div id="largeobj_idm140214667304720" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3274508/table/tbl1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tblfn1"><sup>*</sup>The number of case patients is indicated by Epstein–Barr virus (EBV) status. ARCAGE = Alcohol Related Cancers and Genetic Susceptibility in Europe, used the Illumina HumanHap300 genotyping platform (Illumina Inc); CE = National Cancer Institute and International Agency for Research on Cancer Study in Central Europe, used the Illumina HumanHap300 genotyping platform; GWAS = genome-wide association study; HUNT2/Tromsø = Nord-Trøndelag Health and Tromsø IV Studies, used the Illumina HumanHap300 genotyping platform; NBS = Nijmegen Biomedical Study, used the Illumina CNV370-Duo genotyping platform (Illumina Inc); PANSCAN = Pancreatic Cancer Cohort Consortium, used the Illumina HumanHap550 genotyping platform (Illumina Inc); and WTCCC = Wellcome Trust Case–Control Consortium, used the Illumina Human 1.2M-Duo genotyping platform (Illumina Inc).</div><div id="tblfn2"><sup>†</sup>Generic control subjects were selected on the basis of country of the case patient recruitment from several previously published genome-wide association studies of other cancers.</div><div id="tblfn3"><sup>‡</sup>The Scotland and Newcastle Lymphoma Group series is composed of the Scotland and Newcastle Epidemiological Study of Hodgkin's Disease conducted during 1993–1997 and the local case series, a prospectively collected series during 1992–2008.</div></div></div><p id="__p21" class="p p-last">A large series of generic control subjects were selected on the basis of the country of recruitment of case patients from several previously published GWAS of other cancers conducted among populations of European ancestry (<a href="/pmc/articles/PMC3274508/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). These studies included the Alcohol Related Cancers and Genetic Susceptibility in Europe Study (<a href="#bib15" rid="bib15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945968">15</a>); the International Agency for Research on Cancer Central Europe Study (<a href="#bib16" rid="bib16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945956">16</a>); the Pancreatic Cancer Cohort Consortium (<a href="#bib17" rid="bib17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945910">17</a>); the Nijmegen Biomedical Study (<a href="#bib18" rid="bib18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945927">18</a>); the Nord-Trøndelag Health Study and Tromsø IV Studies (<a href="#bib19" rid="bib19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945922">19</a>,<a href="#bib20" rid="bib20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945914">20</a>); and the Wellcome Trust Case–Control Consortium (<a href="#bib21" rid="bib21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945959">21</a>). From these six studies, genome-wide data from a total of 6466 control subjects were assembled.</p></div><div id="__sec13" class="sec"><h3 id="__sec13title">Genome-Wide Genotyping and Quality Control</h3><p id="__p22" class="p p-first">Genome-wide genotyping of cHL case patient samples was performed using the Illumina Infinium Human660-Quad BeadChip (Illumina Inc, San Diego, CA) at the Centre National de Génotypage (Evry, France; <a href="http://www.cng.fr/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.cng.fr/</a>), as described previously (<a href="#bib22" rid="bib22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945934">22</a>). These case patients were matched with control populations genotyped on Illumina BeadChips (Illumina Inc) from six previous GWAS (described above and <a href="/pmc/articles/PMC3274508/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>).</p><p id="__p23">We conducted systematic quality control steps separately within case patient samples and each of the six different control sample series. A single-nucleotide polymorphism (SNP) was excluded if it was not successfully genotyped in 98% or more of samples, the distribution of genotypes clearly deviated from that expected by Hardy–Weinberg equilibrium (<em>P</em> &lt; 1 × 10<sup>−7</sup>), or the minor allele frequency was less than 0.01. These exclusions resulted in a total of 502 514 SNPs with at least partial genotype data available for both case patients and control subjects.</p><p id="__p24">In addition, quality control metrics were applied to the 1238 cHL case patients resulting in the exclusion of nine samples with less than a 95% overall genotyping success rate, six samples with outlying autosomal heterozygosity rates (&gt;6 SDs from the mean), and three self-reported males and two females with abnormal X chromosome heterozygosity rates of greater than 10% and less than 20%, respectively. Relatedness was evaluated on the basis of an identity by descent analysis (evaluation of whether loci are identical copies of the same ancestral allele) (<a href="#bib23" rid="bib23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945942">23</a>) leading to the exclusion of an additional five samples (ie, first-degree relatives) (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 1</a>, available online).</p><p id="__p25" class="p p-last">To maximize the ethnic homogeneity of the case patient and control subject series, we performed a principal components analysis using a subseries of 11 029 SNPs present on all Illumina BeadChip panels (Illumina Inc) that are evenly distributed across the genome in low linkage disequilibrium (LD) (<em>r</em><sup>2</sup> &lt; 0.004) (<a href="#bib24" rid="bib24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945921">24</a>) and that passed quality control requirements. The principal components analysis was conducted using EIGENSTRAT of the EIGENSOFT 3.0 software package (Broad Institute, Cambridge, MA) (<a href="#bib25" rid="bib25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945896">25</a>). This resulted in further exclusion of 62 outliers (13 patients and 49 control subjects) resulting in a total of 1200 cHL case patients and 6417 control subjects available for the genome-wide analysis (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 1</a>, available online).</p></div><div id="__sec14" class="sec"><h3 id="__sec14title">Technical Replication</h3><p id="__p26" class="p p-first-last">The technical replication stage involved re-genotyping all 1200 cHL patients included in the GWAS and genotyping for the first time 1395 study-specific control subjects for 20 SNPs that reached genome-wide significance in the analysis of total cHL or the subgroup analyses by tumor EBV status. These included 19 SNPs from the MHC region (selected from among &gt;100 genome-wide significant MHC region SNPs based on LD pruning at <em>r</em><sup>2</sup> &lt; 0.2 with an effort to retain SNPs with the lowest <em>P</em> values) and one SNP at chromosomal region 5q31 (<em>IL13</em>, rs20541). Technical replication genotyping was performed using the Sequenom platform (Sequenom Inc, San Diego, CA) at the Centre National de Génotypage (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 2</a>, available online). This stage served two purposes: 1) it allowed for the assessment of genotyping error in the GWAS through re-genotyping select SNPs by an alternate genotyping technology, and 2) it allowed us to confirm the GWAS findings in an analysis of GWAS case patients and study-specific control subjects and aided in the evaluation of bias possibly introduced by the use of generic control subjects in the GWAS.</p></div><div id="__sec15" class="sec"><h3 id="__sec15title">Independent Replication</h3><p id="__p27" class="p p-first">Further evaluation of the independence of the associations between cHL and the 20 technical replication SNPs identified five SNPs within the MHC region and one at 5q31 (rs20541) that best explain the associations with each locus. Three of the six SNPs have not been previously reported in the cHL literature. Thus, they were studied in the independent replication series comprising a different sample of 563 case patients and 613 control subjects from EPILYMPH (<a href="#bib12" rid="bib12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945960">12</a>), the Scotland and Newcastle Lymphoma Group (<a href="#bib6" rid="bib6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945909">6</a>,<a href="#bib9" rid="bib9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945901">9</a>), the Young Adult Hodgkin's Disease Case–Control Study (<a href="#bib13" rid="bib13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945958">13</a>), and the Epidemiology and Genetics Lymphoma Case–Control Study conducted between January 1998 and July 2003 (<a href="http://www.elccs.info" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.elccs.info</a>) (<a href="#bib26" rid="bib26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945944">26</a>) (<a href="/pmc/articles/PMC3274508/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). The rs20541 SNP has been associated with psoriasis and asthma in previous GWAS (<a href="#bib27" rid="bib27" class=" bibr popnode">27</a>–<a href="#bib31" rid="bib31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341811234">31</a>). One additional psoriasis SNP that showed a putative association in the cHL GWAS, rs27524 (<em>ERAP1</em>), was selected for independent replication on the basis of the hypothesis that there may be overlap in the biological mechanisms of the two immune-related diseases. In total, four SNPs were included in the independent replication stage.</p><p id="__p28" class="p p-last">Genotyping was performed using TaqMan Pre-Designed SNP Genotyping Assays (Applied Biosystems, Carlsbad, CA) in 384-well plates for variants rs27524, rs20541, rs2248462 (6p21: <em>MICB</em>), and rs2395185 (6p21: <em>HLA-DRA</em>), including 3.6% duplicate samples. A specific TaqMan Pre-Designed SNP Genotyping Assay Mix (containing probes and primers) was used for each SNP (Applied Biosystems assay-on-demand order code: C___3056837_10 for rs27524, C___2259921_20 for rs20541, C___16026475_10 for rs2248462, and C___16222465_10 for rs2395185). Assays were run on the GeneAmp PCR System 9700 thermal cycler (Applied Biosystems) for 15 minutes at 95°C followed by 30 cycles at 95°C for 15 seconds and a 1-minute incubation at 60°C. Subsequently, the endpoint fluorescence was read with an ABI Prism 7900HT Sequence Detection System, and genotypes were “called” using the SDS 2.1 software (Applied Biosystems). The performance of the assays was validated by re-genotyping CEU HapMap samples (US residents with northern and western European ancestry) and comparing the results to HapMap genotypes (<a href="http://hapmap.ncbi.nlm.nih.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hapmap.ncbi.nlm.nih.gov</a>). All assays were found to be functioning robustly. Within the study samples, duplicates genotyping concordance was greater than 99%.</p></div><div id="__sec16" class="sec"><h3 id="__sec16title">Tumor EBV Status Classification</h3><p id="__p29" class="p p-first">HL EBV status was ascertained through in situ hybridization for EBERs and/or through immunohistochemical staining for EBV LMP-1 protein on formalin-fixed paraffin-embedded tumor samples, with commercially available reagents and protocols that are used in diagnostic settings (<a href="#bib32" rid="bib32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945908">32</a>–<a href="#bib34" rid="bib34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945916">34</a>). In most patients, in situ hybridization was performed to detect EBER1-2 RNAs, which are associated with latent EBV infection, by using an EBER-specific peptide nucleic acid probe according to the manufacturer's instructions (DAKO, Glostrup, Denmark). An appropriate positive control (known EBV-positive HL case) was included.</p><p id="__p30" class="p p-last">Immunohistochemical staining for EBV LMP-1 protein was typically used to supplement the in situ hybridization analyses, but in a small proportion of samples (&lt;10%), EBV LMP-1 staining was the only test for EBV. Following antigen retrieval, paraffin sections were incubated with the antibody cocktail CS1-4 (DAKO). Reactivity was detected using standard EnVision (DAKO), VECTASTAIN ABC (Vector Laboratories, Peterborough, UK), or Ventana kit (Ventana, Tuscon, AZ) immunohistochemistry. EBV-positive patients were defined as those for whom their HRS cells expressed EBERs or LMP-1 protein (<a href="#bib35" rid="bib35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945928">35</a>).</p></div><div id="__sec17" class="sec sec-last"><h3 id="__sec17title">Statistical Analysis</h3><p id="__p31" class="p p-first">The association between each genetic variant and the disease phenotype was estimated by the odds ratio (OR) per allele and 95% confidence intervals (CIs) using multiple logistic regression, assuming a log-additive genetic model with sex (male or female) and country of recruitment (France, Germany, Spain, Czech Republic, Ireland, United Kingdom, Denmark, Sweden, and the Netherlands; up to eight indicator variables after excluding one country as the reference, depending on the analysis) included in the model as covariates. To adjust for any additional population stratification not captured by adjustment for country, eight principal components analysis eigenvectors, which were suggested to be informative based on the Tracy–Widom statistic (<em>P</em> &lt; .05), were included in the regression model (<a href="#bib36" rid="bib36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945965">36</a>). To evaluate the independence of the associations between cHL and multiple SNPs, additional model variables representing the variants in question were included together in a single logistic regression model. Results of the genome-wide and independent replication analyses were combined with meta-analyses applying the inverse variance weighting method (<a href="#bib37" rid="bib37" class=" bibr popnode">37</a>). Between-study heterogeneity in risk estimate was evaluated using the Cochran <em>Q</em> test statistic. Differences for which <em>P</em> values were less than 1.0 × 10<sup>−7</sup> were considered statistically significant at the genome-wide level (<a href="#bib21" rid="bib21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945920">21</a>).</p><p id="__p32" class="p p-last">Genome-wide analyses were conducted for total cHL and for EBV-positive and EBV-negative cHL as the phenotypes of interest. For SNPs that were identified as being associated with cHL, analyses were also conducted on subtypes that were defined using both histology (NSHL or MCHL) and tumor EBV status. The χ<sup>2</sup> test of homogeneity was used to test the null hypothesis that the subtype-specific odds ratios were equal. Genome-wide analyses were not stratified by sex to minimize the total number of statistical tests performed in light of no compelling previously published evidence for strong sex-specific differences in genetic associations. The study population included only whites of European origin; thus, no analyses by racial/ethnic groups were performed. All statistical tests were two-sided. Analyses were conducted using PLINK (<a href="#bib23" rid="bib23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945955">23</a>) and SAS software version 9 (SAS, Cary, NC) (<a href="#bib38" rid="bib38" class=" bibr popnode">38</a>).</p></div></div><div id="__sec18" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec18title">Results</h2><p id="__p33" class="p p-first">The GWAS analysis included 1200 cHL case patients, of which tumor EBV data were available for 933 (77.8%) of 1200 patients. Of the EBV-classified patients, 265 (28.4%) of 933 were EBV-positive (<a href="/pmc/articles/PMC3274508/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). The control subject series consisted of 6417 control subjects with existing genome-wide SNP data representing the countries from which the patients were recruited (<a href="/pmc/articles/PMC3274508/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a> and <a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 3</a>, available online). The overall analysis of cHL and 502 514 SNPs adjusting for sex, country, and eight principal components analysis eigenvectors showed minimal evidence of genomic inflation (λ = 1.04 when adjusted to a sample size of 1000 case patients and 1000 control subjects) (<a href="#bib39" rid="bib39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945939">39</a>) (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Figure 1</a>, available online).</p><div id="__sec19" class="sec"><h3 id="__sec19title">MHC Region</h3><p id="__p34" class="p p-first">Strong associations were observed between cHL and SNPs within the MHC region (chromosomal region 6p21) (<a href="/pmc/articles/PMC3274508/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure 1</span></a>). Because of the availability of EBV status for the large majority of the cHL patients, three groups of risk-associated variants were distinguishable: those relevant to total cHL, EBV-positive cHL, and EBV-negative cHL (<a href="/pmc/articles/PMC3274508/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure 2</span></a> and <a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Figure 2</a>, available online). Two loci showed strong evidence of association with total cHL, with no evidence of heterogeneity in effect by tumor EBV status or histological subtype (<a href="/pmc/articles/PMC3274508/table/tbl2/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a> and <a href="/pmc/articles/PMC3274508/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure 3</span></a>). One of these, indexed by SNP rs2248462, located in the class I region nearing the border with the class III region at the <em>MICB</em> gene, was associated with a reduced risk of cHL (OR = 0.61, 95% CI = 0.53 to 0.69, <em>P</em> = 1.3 × 10<sup>−13</sup>). A reduced risk of cHL was also independently associated with rs2395185 (OR = 0.56, 95% CI = 0.50 to 0.62, <em>P</em> = 8.3 × 10<sup>−25</sup>), a class II SNP located at <em>HLA-DRA</em>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="tbl2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p35">Relationship between five single-nucleotide polymorphisms (SNPs) located within the major histocompatibility complex (MHC) region and total classical Hodgkin lymphoma (cHL), Epstein–Barr virus (EBV)–positive cHL, or EBV-negative cHL subgroups</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140214670749024" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td rowspan="2" colspan="1" valign="bottom">SNP</td><td rowspan="2" colspan="1" valign="bottom" align="center">Position (region in MHC)</td><td rowspan="2" colspan="1" valign="bottom" align="center">Gene candidate</td><td colspan="3" rowspan="1" valign="bottom" align="center">Frequency<sup>*</sup><hr></td><td colspan="2" rowspan="1" valign="bottom" align="center">Single SNP<sup>†</sup><hr></td><td colspan="2" rowspan="1" valign="bottom" align="center">Mutually adjusted<sup>†</sup><hr></td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">Minor allele</td><td rowspan="1" colspan="1" valign="bottom" align="center">Patients</td><td rowspan="1" colspan="1" valign="bottom" align="center">Control subjects</td><td rowspan="1" colspan="1" valign="bottom" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="bottom" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Total cHL<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    rs2248462</td><td rowspan="1" colspan="1" align="center">31554775 (class I)</td><td rowspan="1" colspan="1" align="center"><em>MICB</em></td><td rowspan="1" colspan="1" align="center">A</td><td rowspan="1" colspan="1" align="center">0.14</td><td rowspan="1" colspan="1" align="center">0.22</td><td rowspan="1" colspan="1" align="center">0.61 (0.53 to 0.69)</td><td rowspan="1" colspan="1" align="center">1.3 × 10<sup>−13</sup></td><td rowspan="1" colspan="1" align="center">0.71 (0.62 to 0.81)</td><td rowspan="1" colspan="1" align="center">8.8 × 10<sup>−7</sup></td></tr><tr><td rowspan="1" colspan="1">    rs2395185</td><td rowspan="1" colspan="1" align="center">32541145 (class II)</td><td rowspan="1" colspan="1" align="center"><em>HLA-DRA</em></td><td rowspan="1" colspan="1" align="center">T</td><td rowspan="1" colspan="1" align="center">0.21</td><td rowspan="1" colspan="1" align="center">0.33</td><td rowspan="1" colspan="1" align="center">0.56 (0.50 to 0.62)</td><td rowspan="1" colspan="1" align="center">8.3 × 10<sup>−25</sup></td><td rowspan="1" colspan="1" align="center">0.75 (0.65 to 0.85)</td><td rowspan="1" colspan="1" align="center">9.6 × 10<sup>−6</sup></td></tr><tr><td rowspan="1" colspan="1">EBV-positive cHL<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    rs2734986</td><td rowspan="1" colspan="1" align="center">29926547 (class I)</td><td rowspan="1" colspan="1" align="center"><em>HLA-A</em></td><td rowspan="1" colspan="1" align="center">C</td><td rowspan="1" colspan="1" align="center">0.34</td><td rowspan="1" colspan="1" align="center">0.18</td><td rowspan="1" colspan="1" align="center">2.45 (2.00 to 3.00)</td><td rowspan="1" colspan="1" align="center">1.2 × 10<sup>−15</sup></td><td rowspan="1" colspan="1" align="center">1.83 (1.43 to 2.34)</td><td rowspan="1" colspan="1" align="center">1.5 × 10<sup>−6</sup></td></tr><tr><td rowspan="1" colspan="1">    rs6904029</td><td rowspan="1" colspan="1" align="center">30051046 (class I)</td><td rowspan="1" colspan="1" align="center"><em>HCG9</em></td><td rowspan="1" colspan="1" align="center">A</td><td rowspan="1" colspan="1" align="center">0.17</td><td rowspan="1" colspan="1" align="center">0.30</td><td rowspan="1" colspan="1" align="center">0.46 (0.36 to 0.59)</td><td rowspan="1" colspan="1" align="center">5.5 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">0.59 (0.45 to 0.76)</td><td rowspan="1" colspan="1" align="center">7.3 × 10<sup>−5</sup></td></tr><tr><td rowspan="1" colspan="1">EBV-negative cHL<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    rs6903608</td><td rowspan="1" colspan="1" align="center">32536263 (class II)</td><td rowspan="1" colspan="1" align="center"><em>HLA-DRA</em></td><td rowspan="1" colspan="1" align="center">C</td><td rowspan="1" colspan="1" align="center">0.46</td><td rowspan="1" colspan="1" align="center">0.29</td><td rowspan="1" colspan="1" align="center">2.08 (1.84 to 2.35)</td><td rowspan="1" colspan="1" align="center">6.1 × 10<sup>−31</sup></td><td rowspan="1" colspan="1" align="center">1.88 (1.62 to 2.17)</td><td rowspan="1" colspan="1" align="center">3.1 × 10<sup>−17</sup></td></tr></tbody></table></div><div id="largeobj_idm140214670749024" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3274508/table/tbl2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tblfn4"><sup>*</sup>Frequency of the minor allele in case patients and control subjects included in each analysis.</div><div id="tblfn5"><sup>†</sup>Odds ratios (ORs) and 95% confidence intervals (CIs) for each SNP in the single SNP analysis were derived using logistic regression assuming a log-additive genetic model of inheritance and adjusting for sex (male or female), country (up to eight indicator variables after excluding one country as the reference, depending on the analysis: France, Germany, Spain, Czech Republic, Ireland, United Kingdom, Denmark, Sweden, and the Netherlands), and eight principal components analysis eigenvectors. The mutually adjusted analysis included additional adjustment for the effects of all other SNPs in the table. All statistical tests were two-sided.</div><div id="tblfn6"><sup>‡</sup>Indicates the phenotype with which the SNP appears to be predominately associated based on the results of the total cHL and EBV-specific subtype analyses.</div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC3274508/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140214672453840" class="figure"><a href="/pmc/articles/PMC3274508/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3274508_jncidjr516f01_4c.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is jncidjr516f01_4c.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3274508/bin/jncidjr516f01_4c.jpg"></a></div><div id="largeobj_idm140214672453840" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3274508/figure/fig1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC3274508/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p39">Genome-wide association analysis of 502 514 single-nucleotide polymorphisms (SNPs) in 1200 classical Hodgkin lymphoma patients and 6417 control subjects. Multiple logistic regression analysis was performed assuming a log-additive genetic model and adjusting for sex (male or female), country (eight indicator variables after excluding one country as the reference: France, Germany, Spain, Czech Republic, Ireland, United Kingdom, Denmark, Sweden, and the Netherlands), and eight principal components analysis eigenvectors. The −log<sub>10</sub> (<em>P</em> value) for each SNP is plotted against their chromosomal position. All statistical tests were two-sided. The horizontal <strong>dotted line</strong> represents the genome-wide significance threshold level (<em>P</em> &lt; 1 × 10<sup>−7</sup>). The regions in which SNPs associated with classical Hodgkin lymphoma are located include 5q31 in the vicinity of the <em>IL13</em> and <em>IL4</em> genes, and 6p21 within the major histocompatibility complex (MHC) region.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC3274508/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140214672588384" class="figure"><a href="/pmc/articles/PMC3274508/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3274508_jncidjr516f02_4c.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is jncidjr516f02_4c.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3274508/bin/jncidjr516f02_4c.jpg"></a></div><div id="largeobj_idm140214672588384" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3274508/figure/fig2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_fig2"><div><a class="figpopup" href="/pmc/articles/PMC3274508/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p40">Investigation of the association between genetic variants and total classical Hodgkin lymphoma (cHL), Epstein–Barr virus (EBV)–positive cHL and EBV-negative cHL within an approximately 6.5 Mb region of the extended major histocompatibility complex located at 6p21. Overlayed plots of the −log<sub>10</sub> (<em>P</em> values) for 1973 single-nucleotide polymorphisms (SNPs) by their chromosomal position resulting from three separate analyses of all patients who have cHL (total cHL, in <strong>gray</strong>), patients who have EBV-positive cHL (in <strong>blue</strong>), and patients who have EBV-negative cHL (in <strong>red</strong>) are shown. Multiple logistic regression analysis was performed assuming a log-additive genetic model and adjusting for sex (male or female), country (up to eight indicator variables after excluding one country as the reference, depending on the analysis: France, Germany, Spain, Czech Republic, Ireland, United Kingdom, Denmark, Sweden, and the Netherlands), and eight principal components analysis eigenvectors. All statistical tests were two-sided. <strong>Arrows</strong> indicate cHL-associated regions indexed by five SNPs.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig3" co-legend-rid="lgnd_fig3"><a href="/pmc/articles/PMC3274508/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140214670694512" class="figure"><a href="/pmc/articles/PMC3274508/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3274508_jncidjr516f03_lw.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is jncidjr516f03_lw.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3274508/bin/jncidjr516f03_lw.jpg"></a></div><div id="largeobj_idm140214670694512" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3274508/figure/fig3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_fig3"><div><a class="figpopup" href="/pmc/articles/PMC3274508/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p41">Stratified and subgroup analyses of five single-nucleotide polymorphisms (SNPs) within the major histocompatibility complex region, which were independently associated with classical Hodgkin lymphoma (cHL). Results are shown for <strong>A</strong>) rs2248462 (class I region, <em>MICB</em>), <strong>B</strong>) rs2395185 (class II region, <em>HLA-DRA</em>), <strong>C</strong>) rs2734986 (class I region, <em>HLA-A</em>), <strong>D</strong>) rs6904029 (class I region, <em>HCG9</em>), and <strong>E</strong>) rs6903608 (class II region, <em>HLA-DRA</em>). Odds ratios (ORs, represented by <strong>boxes</strong> with the area of each box inversely proportional to the variance of the estimate) and 95% confidence intervals (CIs, <strong>error bars</strong>) were derived using multiple logistic regression assuming a log-additive genetic model and adjusting for sex (male or female), country (up to eight indicator variables after excluding one country as the reference, depending on the analysis: France, Germany, Spain, Czech Republic, Ireland, United Kingdom, Denmark, Sweden, and the Netherlands), and eight principal components analysis eigenvectors for the genome-wide association study (GWAS) analyses only. The <strong>dashed vertical line</strong> represents the OR of the SNP in the analysis of total cHL among all subjects, and the width of the <strong>diamond</strong> is the corresponding 95% CI. In the analysis stratified by study, the GWAS included the EPILYMPH study (EPILYMH-GWAS), Scandinavian Lymphoma Etiology Study (SCALE-GWAS), the Scotland and Newcastle Lymphoma Group, and Young Adult Hodgkin Case–Control Study analyzed together (referred to as the UK Studies-GWAS), and the Northern Dutch Hodgkin Lymphoma Study (Netherlands-GWAS). The independent replication was done with data from the EPILYMPH study (EPILYMPH - Replication), and the Scotland and Newcastle Lymphoma Group, Young Adult Hodgkin Case–Control Study, and Epidemiology and Genetics Lymphoma Case–Control Study analyzed together (referred to as the UK Studies-Replication). <em>P</em><sub>homogeneity</sub> was on the basis of the Cochran <em>Q</em> test statistic and was used to evaluate between-study heterogeneity in results. Associations between the SNPs and cHL subgroups (including histological subtype, EBV status, and age) were performed, and <em>P</em> values (<em>P</em><sub>homogeneity</sub>) for the χ<sup>2</sup> test of homogeneity are presented to indicate differences in the OR between subgroup analyses. For rs2248462 (<strong>A</strong>) and rs 2395185 (<strong>B</strong>), results were derived from a combined analysis of the GWAS and independent replication phase results using an inverse variance weighting meta-analysis. All statistical tests were two-sided. Ca = case patients; Chr = chromosome; Co = control subjects; MCHL = mixed cellularity Hodgkin lymphoma; NSHL = nodular sclerosis Hodgkin lymphoma.</p></div></div></div><p id="__p42">Multiple SNPs in the class I region were associated with EBV-positive cHL with only limited evidence of an association with EBV-negative cHL (<em>P</em><sub>homogeneity</sub> &lt; .001) (<a href="/pmc/articles/PMC3274508/table/tbl2/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a> and <a href="/pmc/articles/PMC3274508/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure 3</span></a>). Most notable was the variant rs2734986 (OR = 2.45, 95% CI = 2.00 to 3.00, <em>P</em> = 1.2 × 10<sup>−15</sup>) and another class I SNP in weak LD (<em>r</em><sup>2</sup> &lt; 0.10), rs6904029, which showed an independent association with EBV-positive cHL (OR = 0.46, 95% CI = 0.36 to 0.59, <em>P</em> = 5.5 × 10<sup>−10</sup>). Previously genotyped <em>HLA-A</em> data were available for the majority of patients (257 EBV-positive and 642 EBV-negative cHL), and strong LD was observed for rs2734986 (<em>r</em><sup>2</sup> = 0.98) and rs6904029 (<em>r</em><sup>2</sup> = 0.88) with the previously documented <em>HLA-A*01</em> and <em>A*02</em> allelic groups, respectively (<a href="#bib9" rid="bib9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945925">9</a>).</p><p id="__p43" class="p p-last">Also within the MHC in the class II region, a marked cHL association was found for rs6903608 (OR = 1.71, 95% CI = 1.55 to 1.89, <em>P</em> = 3.2 × 10<sup>−27</sup>), a SNP previously reported (<a href="#bib11" rid="bib11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_478821578">11</a>) (<a href="/pmc/articles/PMC3274508/table/tbl2/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>, <a href="/pmc/articles/PMC3274508/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure 2</span></a>, and <a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Figure 2</a>, available online). Strong evidence of heterogeneity in the risk estimate by tumor EBV status for rs6903608 was observed (<em>P</em><sub>homogeneity</sub> &lt; .001). SNP rs6903608 showed no association with EBV-positive cHL (OR = 0.95, 95% CI = 0.78 to 1.16, <em>P</em> = .63), but a markedly increased risk of EBV-negative cHL was observed (OR = 2.08, 95% CI = 1.84 to 2.35, <em>P</em> = 6.1 × 10<sup>−31</sup>) (<a href="/pmc/articles/PMC3274508/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure 3</span></a>). An analysis including the five currently reported MHC region SNPs (rs2248462, rs2395185, rs2734986, rs6904029, and rs6903608) in a single logistic regression model showed that all were independently associated with the risk of total cHL and/or EBV subtype–specific cHL (<a href="/pmc/articles/PMC3274508/table/tbl2/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>).</p></div><div id="__sec20" class="sec"><h3 id="__sec20title">Non-MHC Regions</h3><p id="__p44" class="p p-first">The genome-wide analysis also indicated a strong signal originating from the chromosomal region 5q31 in proximity to the <em>IL13</em> and <em>IL4</em> genes (<a href="/pmc/articles/PMC3274508/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure 1</span></a>). An increased risk of cHL was associated with the minor allele of rs20541 (<a href="/pmc/articles/PMC3274508/table/tbl3/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl3" rid-ob="ob-tbl3" co-legend-rid=""><span>Table 3</span></a> and <a href="/pmc/articles/PMC3274508/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Figure 4</span></a>), which appeared predominately in EBV-negative cHL (OR = 1.53, 95% CI = 1.32 to 1.76, <em>P</em> = 5.4 × 10<sup>−9</sup>). The rs20541 variant has been shown to be involved in the genetic susceptibility to psoriasis and asthma in recently published GWAS (<a href="#bib27" rid="bib27" class=" bibr popnode">27</a>–<a href="#bib31" rid="bib31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341811235">31</a>). As the overlap suggests that there may be potential similarities in biological mechanism between cHL and these other immune-related diseases, we placed emphasis on SNPs associated with psoriasis and asthma identified by previous GWAS (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 4</a>, available online). One additional SNP, rs27524, was associated with total cHL (OR = 1.21, 95% CI = 1.10 to 1.33, <em>P</em> = 1.5 × 10<sup>−4</sup>) (<a href="/pmc/articles/PMC3274508/table/tbl3/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl3" rid-ob="ob-tbl3" co-legend-rid=""><span>Table 3</span></a> and <a href="/pmc/articles/PMC3274508/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Figure 4</span></a>) after applying a Bonferroni correction for the 20 psoriasis- and asthma-associated SNPs (<em>P</em> &lt; .003) that were considered. The association between total cHL and SNP rs2476601 (chromosomal region 1p13, <em>PTPN22</em>) also showed borderline statistical significance after a Bonferroni correction (<em>P</em> = 3.7 × 10<sup>−3</sup>) (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 4</a>, available online).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="tbl3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p45">Summary of results for four previously unreported loci associated with classical Hodgkin lymphoma (cHL) included in the independent replication phase<sup>*</sup></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140214667197088" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td rowspan="2" colspan="1" valign="bottom">SNP (region)</td><td rowspan="2" colspan="1" valign="bottom" align="center">Position</td><td rowspan="2" colspan="1" valign="bottom" align="center">Gene candidate</td><td colspan="5" rowspan="1" valign="bottom" align="center">Genome-wide analysis<sup>†</sup><hr></td><td colspan="2" rowspan="1" valign="bottom" align="center">Independent replication<sup>‡</sup><hr></td><td colspan="2" rowspan="1" valign="bottom" align="center">Combined<sup>§</sup><hr></td><td rowspan="2" colspan="1" valign="bottom" align="center"><em>P</em><sub>hom</sub><sup>§</sup></td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">Minor allele</td><td rowspan="1" colspan="1" valign="bottom" align="center">Minor allele frequency in patients</td><td rowspan="1" colspan="1" valign="bottom" align="center">Minor allele frequency in control subjects</td><td rowspan="1" colspan="1" valign="bottom" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="bottom" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="bottom" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Total cHL<sup>║</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    rs2248462 (6p21)</td><td rowspan="1" colspan="1" align="center">31554775</td><td rowspan="1" colspan="1" align="center"><em>MICB</em></td><td rowspan="1" colspan="1" align="center">A</td><td rowspan="1" colspan="1" align="center">0.14</td><td rowspan="1" colspan="1" align="center">0.22</td><td rowspan="1" colspan="1" align="center">0.61 (0.53 to 0.69)</td><td rowspan="1" colspan="1" align="center">1.3 × 10<sup>−13</sup></td><td rowspan="1" colspan="1" align="center">0.61 (0.46 to 0.83)</td><td rowspan="1" colspan="1" align="center">1.2 × 10<sup>−3</sup></td><td rowspan="1" colspan="1" align="center">0.61 (0.54 to 0.69)</td><td rowspan="1" colspan="1" align="center">6.9 × 10<sup>−16</sup></td><td rowspan="1" colspan="1" align="center">1.0</td></tr><tr><td rowspan="1" colspan="1">    rs2395185 (6p21)</td><td rowspan="1" colspan="1" align="center">32541145</td><td rowspan="1" colspan="1" align="center"><em>HLA-DRA</em></td><td rowspan="1" colspan="1" align="center">T</td><td rowspan="1" colspan="1" align="center">0.21</td><td rowspan="1" colspan="1" align="center">0.33</td><td rowspan="1" colspan="1" align="center">0.56 (0.50 to 0.62)</td><td rowspan="1" colspan="1" align="center">8.3 × 10<sup>−25</sup></td><td rowspan="1" colspan="1" align="center">0.54 (0.42 to 0.70)</td><td rowspan="1" colspan="1" align="center">1.6 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.55 (0.50 to 0.60)</td><td rowspan="1" colspan="1" align="center">3.8 × 10<sup>−31</sup></td><td rowspan="1" colspan="1" align="center">.90</td></tr><tr><td rowspan="1" colspan="1">    rs27524 (5q15)</td><td rowspan="1" colspan="1" align="center">96127700</td><td rowspan="1" colspan="1" align="center"><em>ERAP1</em></td><td rowspan="1" colspan="1" align="center">A</td><td rowspan="1" colspan="1" align="center">0.40</td><td rowspan="1" colspan="1" align="center">0.36</td><td rowspan="1" colspan="1" align="center">1.21 (1.10 to 1.33)</td><td rowspan="1" colspan="1" align="center">1.5 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">1.29 (1.03 to 1.62)</td><td rowspan="1" colspan="1" align="center">.03</td><td rowspan="1" colspan="1" align="center">1.22 (1.11 to 1.33)</td><td rowspan="1" colspan="1" align="center">7.4 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">.61</td></tr><tr><td rowspan="1" colspan="1">EBV-negative cHL<sup>║</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    rs20541 (5q31)</td><td rowspan="1" colspan="1" align="center">132023863</td><td rowspan="1" colspan="1" align="center"><em>IL13</em></td><td rowspan="1" colspan="1" align="center">A</td><td rowspan="1" colspan="1" align="center">0.26</td><td rowspan="1" colspan="1" align="center">0.18</td><td rowspan="1" colspan="1" align="center">1.53 (1.32 to 1.76)</td><td rowspan="1" colspan="1" align="center">5.4 × 10<sup>−9</sup></td><td rowspan="1" colspan="1" align="center">1.18 (0.83 to 1.67)</td><td rowspan="1" colspan="1" align="center">.36</td><td rowspan="1" colspan="1" align="center">1.47 (1.29 to 1.68)</td><td rowspan="1" colspan="1" align="center">1.1 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">.18</td></tr></tbody></table></div><div id="largeobj_idm140214667197088" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3274508/table/tbl3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tblfn7"><sup>*</sup>CI = confidence interval; EBV = Epstein-Barr virus; OR = odds ratio; SNP = single-nucleotide polymorphism.</div><div id="tblfn8"><sup>†</sup>Frequency of the SNP minor allele in case patients and control subjects included in the genome-wide association analysis. ORs and 95% CIs were derived using logistic regression assuming a log-additive genetic model of inheritance and adjusting for sex (male or female), country (up to eight indicator variables after excluding one country as the reference: France, Germany, Spain, Czech Republic, Ireland, United Kingdom, Denmark, Sweden, and the Netherlands, depending on the analysis), and eight principal components analysis eigenvectors. All statistical tests were two-sided.</div><div id="tblfn9"><sup>‡</sup>ORs and 95% CIs were derived using logistic regression assuming a log-additive genetic model of inheritance and adjusting for sex and country. All statistical tests were two-sided.</div><div id="tblfn10"><sup>§</sup>Genome-wide association study and replication phase results were combined using inverse variance weighting meta-analysis. Two-sided <em>P</em> values (<em>P</em><sub>hom</sub>) based on the Cochran <em>Q</em> test statistic were used to evaluate evidence of heterogeneity in risk estimates between the genome-wide association and replication results.</div><div id="tblfn11"><sup>║</sup>Indicates the phenotype within which the SNP appears to be predominately associated based on the results of the total cHL and EBV-specific subtype analyses.</div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig4" co-legend-rid="lgnd_fig4"><a href="/pmc/articles/PMC3274508/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140214669188464" class="figure"><a href="/pmc/articles/PMC3274508/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3274508_jncidjr516f04_4c.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is jncidjr516f04_4c.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3274508/bin/jncidjr516f04_4c.jpg"></a></div><div id="largeobj_idm140214669188464" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3274508/figure/fig4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_fig4"><div><a class="figpopup" href="/pmc/articles/PMC3274508/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p51">Genome-wide association study results in total classical Hodgkin lymphoma for single-nucleotide polymorphisms (SNPs) within a 300-kb flanking region of rs20541 at chromosome 5q31 (left) and rs27524 at chromosome 5q15 (right). Multiple logistic regression was performed assuming a log-additive genetic model and adjusting for sex (male or female), country (eight indicator variables after excluding one country as the reference: France, Germany, Spain, Czech Republic, Ireland, United Kingdom, Denmark, Sweden, and the Netherlands), and eight principal components analysis eigenvectors. The −log<sub>10</sub> (<em>P</em> value) for each SNP are plotted against their chromosomal position. All statistical tests were two-sided. The <strong>black triangle</strong> indicates the reported associated SNP and the <strong>colors of the dots</strong> represent the degree of linkage disequilibrium (based on <em>r</em><sup>2</sup>) in relation to that index SNP. Recombination rates (cM/Mb) overlay the plots and are based on HapMap phase I and II data (<a href="http://hapmap.ncbi.nlm.nih.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hapmap.ncbi.nlm.nih.gov</a>). cM/Mb = centiMorgans/megabase.</p></div></div></div></div><div id="__sec21" class="sec"><h3 id="__sec21title">Technical and Independent Replication</h3><p id="__p52" class="p p-first-last">Subsequent to the GWAS analysis, the key associations between SNPs and cHL were investigated by technical (genotype validation and analysis using study-specific control subjects) and independent (replication of findings in an independent series) replication. In the technical replication, all SNPs had a genotype concordance between the Illumina (Illumina Inc) and Sequenom (Sequenom Inc) platforms of 99% or greater (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 2</a>, available online). Furthermore, the associations were consistent between the analysis using generic and study-specific control subjects (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 5</a>, available online). For the independent replication conducted in the additional series of 563 cHL patients and 613 control subjects for four previously unreported SNPs (rs2248462, rs2395185, rs20541, and rs27524), consistent evidence of associations between rs2248462, rs2395185, and rs27524 and cHL were found with the exception of rs20541 (EBV-negative cHL: OR = 1.18, 95% CI = 0.83 to 1.67, <em>P</em> = .361) (<a href="/pmc/articles/PMC3274508/table/tbl3/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl3" rid-ob="ob-tbl3" co-legend-rid=""><span>Table 3</span></a>). Nevertheless, the combined GWAS and replication results for rs20541 were statistically significant at the genome-wide level (total cHL: OR = 1.38, 95% CI = 1.24 to 1.54, <em>P</em> = 1.8 × 10<sup>−9</sup>; EBV-negative cHL: OR = 1.47, 95% CI = 1.29 to 1.68, <em>P</em> = 1.1 × 10<sup>−8</sup>), but additional studies are needed to confirm this finding (<a href="http://www.jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djr516/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Figure 3</a>, available online).</p></div><div id="__sec22" class="sec sec-last"><h3 id="__sec22title">Associations by Tumor EBV Status in MCHL and NSHL</h3><p id="__p53" class="p p-first">An evaluation of the relationship between cHL and the SNPs by tumor EBV status within the separate MCHL and NSHL histological subtypes was performed. The exclusively EBV-negative cHL association with rs6903608 was largely restricted to the NSHL subtype (<a href="/pmc/articles/PMC3274508/table/tbl4/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl4" rid-ob="ob-tbl4" co-legend-rid=""><span>Table 4</span></a>) with evidence of heterogeneity between EBV-negative NSHL and MCHL (<em>P</em><sub>homogeneity</sub> = .002). The EBV-positive cHL associations with rs2734986 and rs6904029 were observed in both MCHL and NSHL subtypes. However, there was some suggestion that the rs2734986 EBV-positive relationship may be stronger in MCHL compared with NSHL (<em>P</em><sub>homogeneity</sub> = .09).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="tbl4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p54">Results of a genome-wide association analysis of classical Hodgkin lymphoma (cHL) subtypes defined jointly by tumor Epstein–Barr virus (EBV) status and histology<sup>*</sup></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140214708348352" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td rowspan="2" colspan="1" valign="bottom">SNP (gene candidate) by cHL EBV status</td><td colspan="2" rowspan="1" valign="bottom" align="center">Pooled (NSHL and MCHL)<hr></td><td colspan="2" rowspan="1" valign="bottom" align="center">MCHL (n = 154)<hr></td><td colspan="2" rowspan="1" valign="bottom" align="center">NSHL (n = 685)<hr></td><td rowspan="2" colspan="1" valign="bottom" align="center"><em>P</em><sub>hom(MC/NS)</sub><sup>†</sup></td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="bottom" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="bottom" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></td></tr></thead><tbody><tr><td rowspan="1" colspan="1">rs2248462 (<em>MICB</em>)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    EBV-positive cHL</td><td rowspan="1" colspan="1" align="center">0.58 (0.44 to 0.77)</td><td rowspan="1" colspan="1" align="center">1.4 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">0.56 (0.36 to 0.87)</td><td rowspan="1" colspan="1" align="center">.01</td><td rowspan="1" colspan="1" align="center">0.60 (0.42 to 0.85)</td><td rowspan="1" colspan="1" align="center">4.1 × 10<sup>−3</sup></td><td rowspan="1" colspan="1" align="center">.81</td></tr><tr><td rowspan="1" colspan="1">    EBV-negative cHL</td><td rowspan="1" colspan="1" align="center">0.58 (0.49 to 0.70)</td><td rowspan="1" colspan="1" align="center">4.0 × 10<sup>−9</sup></td><td rowspan="1" colspan="1" align="center">0.57 (0.34 to 0.96)</td><td rowspan="1" colspan="1" align="center">.04</td><td rowspan="1" colspan="1" align="center">0.58 (0.48 to 0.71)</td><td rowspan="1" colspan="1" align="center">2.1 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">.95</td></tr><tr><td rowspan="1" colspan="1">    <em>P</em><sub>hom (EBV+/−)</sub></td><td rowspan="1" colspan="1" align="center">.95</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.96</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.87</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">rs2395185 (<em>HLA-DRA</em>)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    EBV-positive cHL</td><td rowspan="1" colspan="1" align="center">0.51 (0.40 to 0.65)</td><td rowspan="1" colspan="1" align="center">4.7 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">0.43 (0.29 to 0.64)</td><td rowspan="1" colspan="1" align="center">3.0 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">0.55 (0.41 to 0.74)</td><td rowspan="1" colspan="1" align="center">6.2 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">.33</td></tr><tr><td rowspan="1" colspan="1">    EBV-negative cHL</td><td rowspan="1" colspan="1" align="center">0.58 (0.50 to 0.67)</td><td rowspan="1" colspan="1" align="center">3.0 × 10<sup>−13</sup></td><td rowspan="1" colspan="1" align="center">0.68 (0.45 to 1.01)</td><td rowspan="1" colspan="1" align="center">.05</td><td rowspan="1" colspan="1" align="center">0.56 (0.48 to 0.66)</td><td rowspan="1" colspan="1" align="center">5.0 × 10<sup>−13</sup></td><td rowspan="1" colspan="1" align="center">.38</td></tr><tr><td rowspan="1" colspan="1">    <em>P</em><sub>hom (EBV+/−)</sub></td><td rowspan="1" colspan="1" align="center">.41</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.11</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.92</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">rs27524 (<em>ERAP1</em>)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    EBV-positive cHL</td><td rowspan="1" colspan="1" align="center">1.30 (1.07 to 1.58)</td><td rowspan="1" colspan="1" align="center">.009</td><td rowspan="1" colspan="1" align="center">1.19 (0.88 to 1.63)</td><td rowspan="1" colspan="1" align="center">.26</td><td rowspan="1" colspan="1" align="center">1.35 (1.06 to 1.72)</td><td rowspan="1" colspan="1" align="center">.02</td><td rowspan="1" colspan="1" align="center">.53</td></tr><tr><td rowspan="1" colspan="1">    EBV-negative cHL</td><td rowspan="1" colspan="1" align="center">1.23 (1.08 to 1.40)</td><td rowspan="1" colspan="1" align="center">.001</td><td rowspan="1" colspan="1" align="center">1.03 (0.71 to 1.48)</td><td rowspan="1" colspan="1" align="center">.88</td><td rowspan="1" colspan="1" align="center">1.26 (1.10 to 1.44)</td><td rowspan="1" colspan="1" align="center">7.0 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">.31</td></tr><tr><td rowspan="1" colspan="1">    <em>P</em><sub>hom (EBV+/−)</sub></td><td rowspan="1" colspan="1" align="center">.65</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.56</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.63</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">rs2734986 (<em>HLA-A</em>)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    EBV-positive cHL</td><td rowspan="1" colspan="1" align="center">2.60 (2.06 to 3.27)</td><td rowspan="1" colspan="1" align="center">7.2 × 10<sup>−16</sup></td><td rowspan="1" colspan="1" align="center">3.35 (2.34 to 4.81)</td><td rowspan="1" colspan="1" align="center">5.5 × 10<sup>−11</sup></td><td rowspan="1" colspan="1" align="center">2.25 (1.68 to 3.00)</td><td rowspan="1" colspan="1" align="center">4.7 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">.09</td></tr><tr><td rowspan="1" colspan="1">    EBV-negative cHL</td><td rowspan="1" colspan="1" align="center">0.95 (0.80 to 1.14)</td><td rowspan="1" colspan="1" align="center">.60</td><td rowspan="1" colspan="1" align="center">1.13 (0.71 to 1.81)</td><td rowspan="1" colspan="1" align="center">.62</td><td rowspan="1" colspan="1" align="center">0.93 (0.77 to 1.12)</td><td rowspan="1" colspan="1" align="center">.46</td><td rowspan="1" colspan="1" align="center">.45</td></tr><tr><td rowspan="1" colspan="1">    <em>P</em><sub>hom (EBV+/−)</sub></td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">rs6904029 (<em>HCG9</em>)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    EBV-positive cHL</td><td rowspan="1" colspan="1" align="center">0.46 (0.36 to 0.60)</td><td rowspan="1" colspan="1" align="center">4.4 × 10<sup>−9</sup></td><td rowspan="1" colspan="1" align="center">0.41 (0.27 to 0.62)</td><td rowspan="1" colspan="1" align="center">3.0 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">0.50 (0.37 to 0.69)</td><td rowspan="1" colspan="1" align="center">1.9 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">.45</td></tr><tr><td rowspan="1" colspan="1">    EBV-negative cHL</td><td rowspan="1" colspan="1" align="center">1.05 (0.92 to 1.20)</td><td rowspan="1" colspan="1" align="center">.47</td><td rowspan="1" colspan="1" align="center">0.99 (0.68 to 1.45)</td><td rowspan="1" colspan="1" align="center">.98</td><td rowspan="1" colspan="1" align="center">1.06 (0.92 to 1.22)</td><td rowspan="1" colspan="1" align="center">.40</td><td rowspan="1" colspan="1" align="center">.74</td></tr><tr><td rowspan="1" colspan="1">    <em>P</em><sub>hom (EBV+/−)</sub></td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.002</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">rs6903608 (<em>HLA-DRA)</em></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    EBV-positive cHL</td><td rowspan="1" colspan="1" align="center">1.05 (0.85 to 1.30)</td><td rowspan="1" colspan="1" align="center">.65</td><td rowspan="1" colspan="1" align="center">0.92 (0.65 to 1.30)</td><td rowspan="1" colspan="1" align="center">.62</td><td rowspan="1" colspan="1" align="center">1.17 (0.90 to 1.52)</td><td rowspan="1" colspan="1" align="center">.24</td><td rowspan="1" colspan="1" align="center">.28</td></tr><tr><td rowspan="1" colspan="1">    EBV-negative cHL</td><td rowspan="1" colspan="1" align="center">2.16 (1.90 to 2.46)</td><td rowspan="1" colspan="1" align="center">1.1 × 10<sup>−31</sup></td><td rowspan="1" colspan="1" align="center">1.23 (0.85 to 1.80)</td><td rowspan="1" colspan="1" align="center">.28</td><td rowspan="1" colspan="1" align="center">2.33 (2.04 to 2.67)</td><td rowspan="1" colspan="1" align="center">2.6 × 10<sup>−34</sup></td><td rowspan="1" colspan="1" align="center">.002</td></tr><tr><td rowspan="1" colspan="1">    <em>P</em><sub>hom (EBV+/−)</sub></td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.27</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">&lt;.001</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">rs20541 (<em>IL13)</em></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">    EBV-positive cHL</td><td rowspan="1" colspan="1" align="center">1.12 (0.88 to 1.43)</td><td rowspan="1" colspan="1" align="center">.37</td><td rowspan="1" colspan="1" align="center">0.84 (0.55 to 1.27)</td><td rowspan="1" colspan="1" align="center">.40</td><td rowspan="1" colspan="1" align="center">1.28 (0.96 to 1.72)</td><td rowspan="1" colspan="1" align="center">.09</td><td rowspan="1" colspan="1" align="center">.11</td></tr><tr><td rowspan="1" colspan="1">    EBV-negative cHL</td><td rowspan="1" colspan="1" align="center">1.54 (1.33 to 1.78)</td><td rowspan="1" colspan="1" align="center">1.0 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">1.36 (0.90 to 2.07)</td><td rowspan="1" colspan="1" align="center">.15</td><td rowspan="1" colspan="1" align="center">1.55 (1.33 to 1.81)</td><td rowspan="1" colspan="1" align="center">2.1 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">.56</td></tr><tr><td rowspan="1" colspan="1">    <em>P</em><sub>hom (EBV+/−)</sub></td><td rowspan="1" colspan="1" align="center">.03</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.11</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.26</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140214708348352" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3274508/table/tbl4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tblfn12"><sup>*</sup>Analysis included only patients with MCHL and NSHL that have EBV status available (MCHL: 89 EBV-positive and 65 EBV-negative patients; NSHL: 146 EBV-positive and 539 EBV-negative patients) and 5653 control subjects. ORs and 95% CIs were derived using logistic regression assuming a log-additive genetic model of inheritance and adjusting for sex (male or female), country (four indicator variables after excluding one country as the reference: Spain, United Kingdom, Denmark, Sweden, and the Netherlands), and eight principal components analysis eigenvectors. <em>P</em><sub>hom (EBV+/-)</sub> comparing the ORs between analyses of EBV-positive and EBV-negative cHL are from two-sided χ<sup>2</sup> tests of homogeneity. All statistical tests were two-sided. CI = confidence interval; MCHL = mixed cellularity Hodgkin lymphoma; NSHL = nodular sclerosis Hodgkin lymphoma; OR = odds ratio.</div><div id="tblfn13"><sup>†</sup><em>P</em><sub>hom (MC/NS)</sub> comparing the ORs between analyses of MCHL and NSHL are from two-sided χ<sup>2</sup> tests of homogeneity.</div></div></div></div></div><div id="__sec23" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec23title">Discussion</h2><p id="__p57" class="p p-first">The large size of the current GWAS including 1200 cHL patients and more than 6000 control subjects, together with EBV and histology information available for the majority of case patients, allowed us to evaluate genome-wide associations by tumor EBV status and further refine the specificity of previously reported susceptibility loci. Overall, we confirmed the strong role of the MHC region supported by five loci independently associated with total cHL or EBV status–specific cHL: rs2248462 (class I region in proximity to <em>MICB</em>) and rs2395185 (class II region, <em>HLA-DRA</em>) are novel loci associated with cHL, irrespective of EBV status. rs2734986 and rs6904029 (class I region, <em>HLA-A</em>) were associated with EBV-positive cHL, and rs6903608 (class II region, <em>HLA-DRA</em>) was associated with EBV-negative cHL and was associated predominately with the NSHL histological subtype. We also showed evidence of an association between cHL and novel loci in close proximity to key immunoregulatory genes at chromosome 5q31 (rs20541, <em>IL13</em>) and 5q15 (rs27524, <em>ERAP1</em>), both of which have also been previously linked to psoriasis.</p><p id="__p58">rs2248462 and rs2395185, both located in the MHC region nearly 1 Mb apart (<em>r</em><sup>2</sup> &lt; 0.1), are independently associated with total cHL with little evidence of heterogeneity in risk estimate by EBV status and histology. The rs2248462 SNP is located in the class I region adjacent to the highly polymorphic MHC class I–related chain (<em>MICB</em>) gene, which encodes a heavily glycosylated protein that is a ligand for the NKG2D receptor. The MICB ligand, structurally resembling the MHC class I glycoproteins, is expressed on epithelial cells in response to cellular stress and activates the cytolytic response of T lymphocytes and natural killer cells that are capable of eliminating tumor and virally infected cells (<a href="#bib40" rid="bib40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945930">40</a>). A previous study examining the MHC region reported an association between cHL and a microsatellite marker that possibly tagged the same susceptibility locus (<a href="#bib8" rid="bib8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945938">8</a>). It involved a broadly associated region centered on the D6S273 microsatellite marker that is located about 100 kb from rs2248462. The second cHL-associated SNP reported in this study, rs2395185, is in the 3′ untranslated region of <em>HLA-DRA</em> in close proximity to the EBV-negative cHL SNP, rs6903608 (<em>r</em><sup>2</sup> = 0.20). However, in contrast to rs6903608, rs2395185 was associated with EBV-positive and EBV-negative cHL, providing evidence that these two SNPs contribute independently to cHL risk.</p><p id="__p59">A cluster of SNPs within the class I region was associated specifically with EBV-positive cHL. The strongest signal was observed for rs2734986 (<em>P</em> = 1.2 × 10<sup>−15</sup>), located in the 3′ untranslated region of <em>HLA-G</em> and in close proximity to the <em>HLA-A</em> locus. Further analysis showed that rs6904029 (located approximately 124 kb downstream in <em>HCG9</em>) was independently associated with EBV-positive cHL. Previous evidence based on a subset of the subjects included in this GWAS showed an increased and decreased risk of EBV-positive cHL associated with <em>HLA-A*01</em> and <em>A*02</em>, respectively (<a href="#bib9" rid="bib9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945900">9</a>,<a href="#bib10" rid="bib10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945915">10</a>). An evaluation among the patients with <em>HLA-A</em> data available showed <em>HLA-A*01</em> to be in strong LD with rs2734986 (<em>r</em><sup>2</sup> = 0.98) but not with rs6904029 (<em>r</em><sup>2</sup> = 0.10). Similarly, <em>HLA-A*02</em> was in LD with rs6904029 (<em>r</em><sup>2</sup> = 0.88) but not with rs2734986 (<em>r</em><sup>2</sup> = 0.10).</p><p id="__p60">The analysis by EBV status showed the class II SNP (<a href="#bib11" rid="bib11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_478821575">11</a>), rs6903608, to be associated only with EBV-negative cHL, whereas no association was observed with EBV-positive cHL. This SNP resides in the 3′ untranslated region of the <em>HLA-DRA</em> locus and is in relatively close proximity to the other HLA class II loci (<em>HLA-DR, HLA-DQ</em>, and <em>HLA-DP</em>), which have been implicated in earlier studies of HL (<a href="#bib41" rid="bib41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945952">41</a>–<a href="#bib44" rid="bib44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945953">44</a>). In our study, we identified an additional level of heterogeneity in the risk estimate of this variant by histological subtype, indicating that associations were predominantly between rs6903608 and EBV-negative NSHL, rather than EBV-negative MCHL. Although cHL histology and EBV status are related, they are far from synonymous. To our knowledge, this is the first study to show clear evidence of a histology-specific association between genetic loci and cHL risk within an EBV-defined series of cHL patients.</p><p id="__p61">In this GWAS, additional genome-wide significant associations between genetic variants and cHL were identified outside of the MHC region within a cytokine gene cluster at chromosomal region 5q31, including a nonsynonymous SNP in the <em>IL13</em> gene (rs20541). rs20541 causes the replacement of a positively charged arginine with a neutral glutamine that has been shown to result in increased activity of IL13, a type 2 helper T cell cytokine (<a href="#bib45" rid="bib45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945894">45</a>). Association studies have also attributed this SNP to increased serum immunoglobulin E levels (<a href="#bib46" rid="bib46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945951">46</a>), atopic conditions (<a href="#bib47" rid="bib47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945905">47</a>), asthma (<a href="#bib28" rid="bib28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945948">28</a>), and psoriasis (<a href="#bib30" rid="bib30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945933">30</a>,<a href="#bib31" rid="bib31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341811233">31</a>). In cHL, IL13 protein expression has been specifically detected in HRS cells (<a href="#bib48" rid="bib48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945924">48</a>) and rarely within the reactive infiltrate of cHL tumors. Evidence from gene expression studies increasingly suggests that this cytokine may function as an autocrine growth factor for the HRS cells in cHL (<a href="#bib49" rid="bib49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945898">49</a>). Involvement of IL13 in cHL is also consistent with a recent GWAS reporting an association between cHL and the <em>GATA3</em> gene (<a href="#bib11" rid="bib11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_478821577">11</a>). GATA3 acts as a master transcription factor for key cytokines, including IL13, in lymphoid cell development (<a href="#bib50" rid="bib50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945912">50</a>), and concordantly aberrant expression of these two genes has been detected in HRS cells derived from cHL tissue (<a href="#bib51" rid="bib51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945967">51</a>). Further support for an involvement of cytokines in cHL has been demonstrated in a recent candidate gene study reporting evidence of epistatic interactions within the inflammatory response pathway (<a href="#bib52" rid="bib52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945945">52</a>).</p><p id="__p62">Although the overall association between rs20541 and cHL (GWAS and replication combined) was statistically significant at the genome-wide level, weak evidence for this relationship was observed in the independent replication series alone. The inconsistency may be partially attributed to insufficient statistical power in the replication series, particularly if the GWAS estimate is overestimated as a consequence of the stringent criteria for genome-wide statistical significance (<a href="#bib53" rid="bib53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945904">53</a>). Notably, in the genome-wide analysis, rs20541 appeared to be predominately associated with EBV-negative cHL. The replication dataset included a total of 563 cHL patients, of which only half were classified as EBV-negative, which may have further influenced statistical power. Although strong evidence in the GWAS was found for an association between rs20541 and cHL, and a biological role for rs20541 in cHL is plausible, this reported association requires further confirmation.</p><p id="__p63">The overlap of the cHL association with rs20541 found in our study with recent GWAS of psoriasis (<a href="#bib31" rid="bib31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341811232">31</a>) and asthma (<a href="#bib28" rid="bib28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945899">28</a>) led us to consider other asthma and psoriasis SNPs as possible candidate loci associated with cHL. In particular, rs27524, which maps to the endoplasmic reticulum aminopeptidase 1 (<em>ERAP1,</em> chromosome 5q15) gene locus, has been strongly associated with psoriasis (<a href="#bib31" rid="bib31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_341811231">31</a>) and has shown evidence of an association with cHL in our genome-wide analysis. A consistent association was observed in the independent replication study and yielded strong evidence in the GWAS and replication combined analysis. ERAP1 is an aminopeptidase involved in the trimming of N-terminal amino acid residues of precursor polypeptides in preparation for loading and antigen presentation by the MHC class I molecule. Aberrant activity of <em>ERAP1</em> (and <em>ERAP2</em>, a gene located in close proximity) expression resulting in impaired antigen processing plays a key role in regulating the surface expression of HLA class I molecules (<a href="#bib54" rid="bib54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945911">54</a>). Fruci et al. (<a href="#bib55" rid="bib55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945961">55</a>) reported consistently high <em>ERAP1</em> expression levels in lymphoblastoid cell lines established from healthy donors, but markedly varied expression levels correlated with surface HLA class I expression in tumor cell lines. Thus, it has been hypothesized that downregulation of HLA class I expression and/or deranged presentation of certain tumor antigens caused by abnormal expression of <em>ERAP1</em> may contribute to the ability of tumor cells to evade immune surveillance (<a href="#bib55" rid="bib55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945919">55</a>).</p><p id="__p64">The nature of a possible relationship of cHL with psoriasis and potentially with other autoimmune diseases is unclear and requires further investigation. Previous epidemiological studies have reported associations between cHL risk and a personal and family history of certain autoimmune diseases, namely rheumatoid arthritis and systemic lupus erythematosus, although the reports have been less consistent for psoriasis (<a href="#bib56" rid="bib56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945962">56</a>). A large retrospective cohort study conducted in the United Kingdom reported a statistically significant increased risk of HL in psoriasis patients (<a href="#bib57" rid="bib57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945932">57</a>). However, there is uncertainty about whether the putative relationship may be attributed to the adverse effects of psoriasis treatment or whether there is some pathophysiological feature common to both diseases (<a href="#bib57" rid="bib57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945966">57</a>,<a href="#bib58" rid="bib58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_249945918">58</a>). Nevertheless, the overlap in genetic risk factors indicated in our study provides support for possible similarities in molecular pathways involved in the pathogenesis of these immune-related diseases.</p><p id="__p65">Our study has several limitations. Although this is the largest GWAS of cHL to date and the first to evaluate EBV status–specific heterogeneity, there may have been insufficient statistical power to detect certain associations within the analysis of the less common cHL subtypes (eg, EBV-positive cHL) and for rarer SNPs and those associated with smaller risk estimates. Assuming a SNP allele frequency of approximately 0.20, the current GWAS sample size had adequate power (&gt;70%) to detect statistically significant (<em>P</em> &lt; 1 × 10<sup>−7</sup>) associations for risk estimates as low as 1.4, 1.9, and 1.5 in the analyses of total cHL, EBV-positive cHL, and EBV-negative cHL, respectively. Presence of systematic bias because of differences in genotyping between patients and the generic control subjects is a possibility. However, consistency with previous literature and successful validation of genotyping together with replication of novel SNP loci in this study make it unlikely that the reported SNPs are false-positive findings. The patients included in this GWAS analysis, with the exception of those from EPILYMPH, have contributed to an independent replication series for a previous GWAS of cHL (<a href="#bib11" rid="bib11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_478821576">11</a>). In consideration of this overlap, we were careful in the interpretation of our findings and pursued only novel loci in the independent replication stage, which included two additional MHC region loci associated irrespective of EBV status, and SNPs at chromosome 5q31 (<em>IL13</em>) and 5q15 (<em>ERAP1</em>).</p><p id="__p66" class="p p-last">In summary, this GWAS identified susceptibility loci that appeared to be common across subtypes of cHL but also noted loci that showed markedly heterogeneous associations with cHL by tumor EBV status. Furthermore, we provided evidence for an overlap in associated loci between cHL and psoriasis. This may indicate some common biological mechanism between the two diseases that can further aid our understanding of cHL pathogenesis.</p></div><div id="__sec24" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec24title">Funding</h2><p id="__p67" class="p p-first-last">This work was supported by L’Institut National du Cancer, France; Spanish Ministry of Health grant CIBERESP (<span>FIS 08-1555</span>; and <span>06/02/0073</span> to S.D.S.); Ministry of Health of the Czech Republic (<span>MZ0 MOU2005</span> to L.F.); German José Carreras Leukemia Foundation (<span>DJCLS_R04/08</span> to A.N.); Federal Office for Radiation Protection (<span>StSch4261</span>; and <span>StSch4420</span> to N.B.); European Commission 5th Framework Program Quality of Life (<span>QLK4-CT-2000-00422</span> to P.Br.); European Commission 6th Framework Program (FP6-2003-FOOD-2-B to P.Bo.); La Fondation de France (<span>1999-008471</span> to M.Ma.); Compagnia di San Paolo - Programma Oncologia (P.C.); Health Research Board, Ireland (A.S.); Leukaemia Research Fund (<span>08031</span>; and <span>05045</span> to R.F.J.); Kay Kendall Leukaemia Fund (R.F.J. and M.T.); United States National Institutes of Health (<span>R01 CA69269</span> to M.Me.), Nordic Cancer Union (<span>16-02-D</span> to H.H.); Plan Danmark; Danish Cancer Research Foundation (<span>41-08</span> to M.Me.); Lundbeck Foundation (<span>R19-A2364</span> to H.H.); Danish Cancer Society (<span>DP 08-155</span> to H.H.); Swedish Cancer Society (<span>2009/1084</span> to K.E.S.); Dutch Cancer Society (KWF grants <span>RUG 2000-2315</span>; and <span>RUG 2010-4860</span> to A.v.d.B.); the Netherlands Organisation of Scientific Research (NWO-MW grant 920-03-136 to A.D.); Leukaemia &amp; Lymphoma Research (<span>00/73</span>; and <span>06001</span> to E.Ro.).</p></div><div id="__sec25" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec25title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="PMC_1">

<!--caption a9--><strong>Supplementary Data:</strong>

<div class="sup-box half_rhythm" id="idm140214665607648"><a href="/pmc/articles/PMC3274508/bin/supp_104_3_240__index.html" data-ga-action="click_feat_suppl">Click here to view.</a></div>

</div></div><div id="idm140214666748544" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140214666748544title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn1"></p><p id="__p68" class="p p-first-last">K. Y. Urayama, R. F. Jarrett, H. Hjalgrim, and A. Diepstra contributed equally to this work. This study used data generated by the Wellcome Trust Case–Control Consortium (<a href="http://www.wtccc.org.uk" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.wtccc.org.uk</a>). The sponsors had no role in the design of the study; the collection, analysis, and interpretation of the data; the writing of the article; and the decision to submit the article for publication.</p><p></p></div></div><div id="idm140214669778640" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140214669778640title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="bib1">1. <span class="element-citation">Curado MP, Edwards B, Shin HR, et al.   <span class="ref-journal">Cancer Incidence in Five Continents. Volume IX.</span> Lyon, France: IARC Scientific Publications; 2007.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Cancer+Incidence+in+Five+Continents.+Volume+IX&amp;author=MP+Curado&amp;author=B+Edwards&amp;author=HR+Shin&amp;publication_year=2007&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib2">2. <span class="element-citation">Swerdlow SH, Campo E, Harris NL, et al.   <span class="ref-journal">WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.</span> 4th ed. Lyon, France: IARC Press; 2008.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=WHO+Classification+of+Tumours+of+Haematopoietic+and+Lymphoid+Tissues&amp;author=SH+Swerdlow&amp;author=E+Campo&amp;author=NL+Harris&amp;publication_year=2008&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib3">3. <span class="element-citation">Kuppers R. The biology of Hodgkin's lymphoma. <span><span class="ref-journal">Nat Rev Cancer. </span>2009;<span class="ref-vol">9</span>(1):15–27.</span> [<a href="/pubmed/19078975" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer.&amp;title=The+biology+of+Hodgkin's+lymphoma&amp;author=R+Kuppers&amp;volume=9&amp;issue=1&amp;publication_year=2009&amp;pages=15-27&amp;pmid=19078975&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib4">4. <span class="element-citation">International Agency for Research on Cancer (IARC) Epstein-Barr virus and Kaposi's sarcoma Herpesvirus/Human Herpesvirus 8. <span></span> <em>IARC Monogr Eval Carcinog Risks Hum</em>. 1997;70:1–492. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5046075/">PMC free article</a>]</span> [<a href="/pubmed/9705682" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=International+Agency+for+Research+on+Cancer+(IARC)+Epstein-Barr+virus+and+Kaposi's+sarcoma+Herpesvirus/Human+Herpesvirus+8+IARC+Monogr+Eval+Carcinog+Risks+Hum+.+1997;70:1–492+" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib5">5. <span class="element-citation">Gulley ML, Eagan PA, Quintanilla-Martinez L, et al.  Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity. <span><span class="ref-journal">Blood. </span>1994;<span class="ref-vol">83</span>(6):1595–1602.</span> [<a href="/pubmed/8123850" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood.&amp;title=Epstein-Barr+virus+DNA+is+abundant+and+monoclonal+in+the+Reed-Sternberg+cells+of+Hodgkin's+disease:+association+with+mixed+cellularity+subtype+and+Hispanic+American+ethnicity&amp;author=ML+Gulley&amp;author=PA+Eagan&amp;author=L+Quintanilla-Martinez&amp;volume=83&amp;issue=6&amp;publication_year=1994&amp;pages=1595-1602&amp;pmid=8123850&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib6">6. <span class="element-citation">Jarrett RF, Krajewski AS, Angus B, et al.  The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. <span><span class="ref-journal">J Clin Pathol. </span>2003;<span class="ref-vol">56</span>(11):811–816.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1770114/">PMC free article</a>]</span> [<a href="/pubmed/14600123" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pathol.&amp;title=The+Scotland+and+Newcastle+epidemiological+study+of+Hodgkin's+disease:+impact+of+histopathological+review+and+EBV+status+on+incidence+estimates&amp;author=RF+Jarrett&amp;author=AS+Krajewski&amp;author=B+Angus&amp;volume=56&amp;issue=11&amp;publication_year=2003&amp;pages=811-816&amp;pmid=14600123&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib7">7. <span class="element-citation">Glaser SL, Lin RJ, Stewart SL, et al.  Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. <span><span class="ref-journal">Int J Cancer. </span>1997;<span class="ref-vol">70</span>(4):375–382.</span> [<a href="/pubmed/9033642" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer.&amp;title=Epstein-Barr+virus-associated+Hodgkin's+disease:+epidemiologic+characteristics+in+international+data&amp;author=SL+Glaser&amp;author=RJ+Lin&amp;author=SL+Stewart&amp;volume=70&amp;issue=4&amp;publication_year=1997&amp;pages=375-382&amp;pmid=9033642&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib8">8. <span class="element-citation">Diepstra A, Niens M, Vellenga E, et al.  Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. <span><span class="ref-journal">Lancet. </span>2005;<span class="ref-vol">365</span>(9478):2216–2224.</span> [<a href="/pubmed/15978930" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet.&amp;title=Association+with+HLA+class+I+in+Epstein-Barr-virus-positive+and+with+HLA+class+III+in+Epstein-Barr-virus-negative+Hodgkin's+lymphoma&amp;author=A+Diepstra&amp;author=M+Niens&amp;author=E+Vellenga&amp;volume=365&amp;issue=9478&amp;publication_year=2005&amp;pages=2216-2224&amp;pmid=15978930&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib9">9. <span class="element-citation">Hjalgrim H, Rostgaard K, Johnson PC, et al.  HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2010;<span class="ref-vol">107</span>(14):6400–6405.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2851961/">PMC free article</a>]</span> [<a href="/pubmed/20308568" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A.&amp;title=HLA-A+alleles+and+infectious+mononucleosis+suggest+a+critical+role+for+cytotoxic+T-cell+response+in+EBV-related+Hodgkin+lymphoma&amp;author=H+Hjalgrim&amp;author=K+Rostgaard&amp;author=PC+Johnson&amp;volume=107&amp;issue=14&amp;publication_year=2010&amp;pages=6400-6405&amp;pmid=20308568&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib10">10. <span class="element-citation">Niens M, Jarrett RF, Hepkema B, et al.  HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">110</span>(9):3310–3315.</span> [<a href="/pubmed/17630352" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood.&amp;title=HLA-A*02+is+associated+with+a+reduced+risk+and+HLA-A*01+with+an+increased+risk+of+developing+EBV++Hodgkin+lymphoma&amp;author=M+Niens&amp;author=RF+Jarrett&amp;author=B+Hepkema&amp;volume=110&amp;issue=9&amp;publication_year=2007&amp;pages=3310-3315&amp;pmid=17630352&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib11">11. <span class="element-citation">Enciso-Mora V, Broderick P, Ma Y, et al.  A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3) <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>(12):1126–1130.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4268499/">PMC free article</a>]</span> [<a href="/pubmed/21037568" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet.&amp;title=A+genome-wide+association+study+of+Hodgkin's+lymphoma+identifies+new+susceptibility+loci+at+2p16.1+(REL),+8q24.21+and+10p14+(GATA3)&amp;author=V+Enciso-Mora&amp;author=P+Broderick&amp;author=Y+Ma&amp;volume=42&amp;issue=12&amp;publication_year=2010&amp;pages=1126-1130&amp;pmid=21037568&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib12">12. <span class="element-citation">Besson H, Brennan P, Becker N, et al.  Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH) <span><span class="ref-journal">Br J Cancer. </span>2006;<span class="ref-vol">95</span>(3):378–384.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2360649/">PMC free article</a>]</span> [<a href="/pubmed/16819547" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Cancer.&amp;title=Tobacco+smoking,+alcohol+drinking+and+Hodgkin's+lymphoma:+a+European+multi-centre+case-control+study+(EPILYMPH)&amp;author=H+Besson&amp;author=P+Brennan&amp;author=N+Becker&amp;volume=95&amp;issue=3&amp;publication_year=2006&amp;pages=378-384&amp;pmid=16819547&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib13">13. <span class="element-citation">Alexander FE, Lawrence DJ, Freeland J, et al.  An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults. <span><span class="ref-journal">Int J Cancer. </span>2003;<span class="ref-vol">107</span>(2):298–302.</span> [<a href="/pubmed/12949811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer.&amp;title=An+epidemiologic+study+of+index+and+family+infectious+mononucleosis+and+adult+Hodgkin's+disease+(HD):+evidence+for+a+specific+association+with+EBV+ve+HD+in+young+adults&amp;author=FE+Alexander&amp;author=DJ+Lawrence&amp;author=J+Freeland&amp;volume=107&amp;issue=2&amp;publication_year=2003&amp;pages=298-302&amp;pmid=12949811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib14">14. <span class="element-citation">Smedby KE, Hjalgrim H, Melbye M, et al.  Ultraviolet radiation exposure and risk of malignant lymphomas. <span><span class="ref-journal">J Natl Cancer Inst. </span>2005;<span class="ref-vol">97</span>(3):199–209.</span> [<a href="/pubmed/15687363" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst.&amp;title=Ultraviolet+radiation+exposure+and+risk+of+malignant+lymphomas&amp;author=KE+Smedby&amp;author=H+Hjalgrim&amp;author=M+Melbye&amp;volume=97&amp;issue=3&amp;publication_year=2005&amp;pages=199-209&amp;pmid=15687363&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib15">15. <span class="element-citation">Lagiou P, Georgila C, Minaki P, et al.  Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection. <span><span class="ref-journal">Eur J Cancer Prev. </span>2009;<span class="ref-vol">18</span>(1):76–84.</span> [<a href="/pubmed/18830131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer+Prev.&amp;title=Alcohol-related+cancers+and+genetic+susceptibility+in+Europe:+the+ARCAGE+project:+study+samples+and+data+collection&amp;author=P+Lagiou&amp;author=C+Georgila&amp;author=P+Minaki&amp;volume=18&amp;issue=1&amp;publication_year=2009&amp;pages=76-84&amp;pmid=18830131&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib16">16. <span class="element-citation">Hashibe M, McKay JD, Curado MP, et al.  Multiple ADH genes are associated with upper aerodigestive cancers. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>(6):707–709.</span> [<a href="/pubmed/18500343" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet.&amp;title=Multiple+ADH+genes+are+associated+with+upper+aerodigestive+cancers&amp;author=M+Hashibe&amp;author=JD+McKay&amp;author=MP+Curado&amp;volume=40&amp;issue=6&amp;publication_year=2008&amp;pages=707-709&amp;pmid=18500343&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib17">17. <span class="element-citation">Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>(9):986–990.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2839871/">PMC free article</a>]</span> [<a href="/pubmed/19648918" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet.&amp;title=Genome-wide+association+study+identifies+variants+in+the+ABO+locus+associated+with+susceptibility+to+pancreatic+cancer&amp;author=L+Amundadottir&amp;author=P+Kraft&amp;author=RZ+Stolzenberg-Solomon&amp;volume=41&amp;issue=9&amp;publication_year=2009&amp;pages=986-990&amp;pmid=19648918&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib18">18. <span class="element-citation">Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. <span><span class="ref-journal">Kidney Int. </span>2007;<span class="ref-vol">72</span>(5):632–637.</span> [<a href="/pubmed/17568781" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int.&amp;title=Age-+and+gender-specific+reference+values+of+estimated+GFR+in+Caucasians:+the+Nijmegen+Biomedical+Study&amp;author=JF+Wetzels&amp;author=LA+Kiemeney&amp;author=DW+Swinkels&amp;author=HL+Willems&amp;author=M+den+Heijer&amp;volume=72&amp;issue=5&amp;publication_year=2007&amp;pages=632-637&amp;pmid=17568781&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib19">19. <span class="element-citation">Holmen TL, Barrett-Connor E, Holmen J, Bjermer L. Health problems in teenage daily smokers versus nonsmokers, Norway, 1995–1997: the Nord-Trondelag Health Study. <span><span class="ref-journal">Am J Epidemiol. </span>2000;<span class="ref-vol">151</span>(2):148–155.</span> [<a href="/pubmed/10645817" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol.&amp;title=Health+problems+in+teenage+daily+smokers+versus+nonsmokers,+Norway,+1995–1997:+the+Nord-Trondelag+Health+Study&amp;author=TL+Holmen&amp;author=E+Barrett-Connor&amp;author=J+Holmen&amp;author=L+Bjermer&amp;volume=151&amp;issue=2&amp;publication_year=2000&amp;pages=148-155&amp;pmid=10645817&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib20">20. <span class="element-citation">Kronborg J, Jenssen T, Njolstad I, Toft I, Eriksen BO. Metabolic risk factors associated with serum creatinine in a non-diabetic population. <span><span class="ref-journal">Eur J Epidemiol. </span>2007;<span class="ref-vol">22</span>(10):707–713.</span> [<a href="/pubmed/17653600" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Epidemiol.&amp;title=Metabolic+risk+factors+associated+with+serum+creatinine+in+a+non-diabetic+population&amp;author=J+Kronborg&amp;author=T+Jenssen&amp;author=I+Njolstad&amp;author=I+Toft&amp;author=BO+Eriksen&amp;volume=22&amp;issue=10&amp;publication_year=2007&amp;pages=707-713&amp;pmid=17653600&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib21">21. <span class="element-citation">The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">447</span>(7145):661–678.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2719288/">PMC free article</a>]</span> [<a href="/pubmed/17554300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature.&amp;title=Genome-wide+association+study+of+14,000+cases+of+seven+common+diseases+and+3,000+shared+controls&amp;volume=447&amp;issue=7145&amp;publication_year=2007&amp;pages=661-678&amp;pmid=17554300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib22">22. <span class="element-citation">Purdue MP, Johansson M, Zelenika D, et al.  Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>(1):60–65.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3049257/">PMC free article</a>]</span> [<a href="/pubmed/21131975" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet.&amp;title=Genome-wide+association+study+of+renal+cell+carcinoma+identifies+two+susceptibility+loci+on+2p21+and+11q13.3&amp;author=MP+Purdue&amp;author=M+Johansson&amp;author=D+Zelenika&amp;volume=43&amp;issue=1&amp;publication_year=2011&amp;pages=60-65&amp;pmid=21131975&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib23">23. <span class="element-citation">Purcell S, Neale B, Todd-Brown K, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>(3):559–575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet.&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;volume=81&amp;issue=3&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib24">24. <span class="element-citation">Yu K, Wang Z, Li Q, et al.  Population substructure and control selection in genome-wide association studies. <span><span class="ref-journal">PLoS One. </span>2008;<span class="ref-vol">3</span>(7):e2551.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2432498/">PMC free article</a>]</span> [<a href="/pubmed/18596976" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One.&amp;title=Population+substructure+and+control+selection+in+genome-wide+association+studies&amp;author=K+Yu&amp;author=Z+Wang&amp;author=Q+Li&amp;volume=3&amp;issue=7&amp;publication_year=2008&amp;pages=e2551&amp;pmid=18596976&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib25">25. <span class="element-citation">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>(8):904–909.</span> [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet.&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=AL+Price&amp;author=NJ+Patterson&amp;author=RM+Plenge&amp;author=ME+Weinblatt&amp;author=NA+Shadick&amp;volume=38&amp;issue=8&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib26">26. <span class="element-citation">Willett EV, O’Connor S, Smith AG, Roman E. Does smoking or alcohol modify the risk of Epstein-Barr virus-positive or -negative Hodgkin lymphoma? <span><span class="ref-journal">Epidemiology. </span>2007;<span class="ref-vol">18</span>(1):130–136.</span> [<a href="/pubmed/17099321" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epidemiology.&amp;title=Does+smoking+or+alcohol+modify+the+risk+of+Epstein-Barr+virus-positive+or+-negative+Hodgkin+lymphoma?&amp;author=EV+Willett&amp;author=S+O’Connor&amp;author=AG+Smith&amp;author=E+Roman&amp;volume=18&amp;issue=1&amp;publication_year=2007&amp;pages=130-136&amp;pmid=17099321&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib27">27. <span class="element-citation"> Hindorff LA, Junkins HA, Hall PN, Mehta JP, Manolio TA. A Catalog of Published Genome-Wide Association Studies.  <a href="http://www.genome.gov/gwastudies" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">www.genome.gov/gwastudies</a>. Accessed March 29, 2011.</span></div><div class="ref-cit-blk half_rhythm" id="bib28">28. <span class="element-citation">Li X, Howard TD, Zheng SL, et al.  Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2010;<span class="ref-vol">125</span>(2):328–335.</span> e311. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2824608/">PMC free article</a>]</span> [<a href="/pubmed/20159242" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol.&amp;title=Genome-wide+association+study+of+asthma+identifies+RAD50-IL13+and+HLA-DR/DQ+regions&amp;author=X+Li&amp;author=TD+Howard&amp;author=SL+Zheng&amp;volume=125&amp;issue=2&amp;publication_year=2010&amp;pages=328-335&amp;pmid=20159242&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib29">29. <span class="element-citation">Moffatt MF, Gut IG, Demenais F, et al.  A large-scale, consortium-based genomewide association study of asthma. <span><span class="ref-journal">N Engl J Med. </span>2010;<span class="ref-vol">363</span>(13):1211–1221.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4260321/">PMC free article</a>]</span> [<a href="/pubmed/20860503" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med.&amp;title=A+large-scale,+consortium-based+genomewide+association+study+of+asthma&amp;author=MF+Moffatt&amp;author=IG+Gut&amp;author=F+Demenais&amp;volume=363&amp;issue=13&amp;publication_year=2010&amp;pages=1211-1221&amp;pmid=20860503&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib30">30. <span class="element-citation">Nair RP, Duffin KC, Helms C, et al.  Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>(2):199–204.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2745122/">PMC free article</a>]</span> [<a href="/pubmed/19169254" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet.&amp;title=Genome-wide+scan+reveals+association+of+psoriasis+with+IL-23+and+NF-kappaB+pathways&amp;author=RP+Nair&amp;author=KC+Duffin&amp;author=C+Helms&amp;volume=41&amp;issue=2&amp;publication_year=2009&amp;pages=199-204&amp;pmid=19169254&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib31">31. <span class="element-citation">Strange A, Capon F, Spencer CC, et al.  A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>(11):985–990.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3749730/">PMC free article</a>]</span> [<a href="/pubmed/20953190" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet.&amp;title=A+genome-wide+association+study+identifies+new+psoriasis+susceptibility+loci+and+an+interaction+between+HLA-C+and+ERAP1&amp;author=A+Strange&amp;author=F+Capon&amp;author=CC+Spencer&amp;volume=42&amp;issue=11&amp;publication_year=2010&amp;pages=985-990&amp;pmid=20953190&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib32">32. <span class="element-citation">Armstrong AA, Alexander FE, Cartwright R, et al.  Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. <span><span class="ref-journal">Leukemia. </span>1998;<span class="ref-vol">12</span>(8):1272–1276.</span> [<a href="/pubmed/9697883" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia.&amp;title=Epstein-Barr+virus+and+Hodgkin's+disease:+further+evidence+for+the+three+disease+hypothesis&amp;author=AA+Armstrong&amp;author=FE+Alexander&amp;author=R+Cartwright&amp;volume=12&amp;issue=8&amp;publication_year=1998&amp;pages=1272-1276&amp;pmid=9697883&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib33">33. <span class="element-citation">Hjalgrim H, Smedby KE, Rostgaard K, et al.  Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. <span><span class="ref-journal">Cancer Res. </span>2007;<span class="ref-vol">67</span>(5):2382–2388.</span> [<a href="/pubmed/17332371" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=Infectious+mononucleosis,+childhood+social+environment,+and+risk+of+Hodgkin+lymphoma&amp;author=H+Hjalgrim&amp;author=KE+Smedby&amp;author=K+Rostgaard&amp;volume=67&amp;issue=5&amp;publication_year=2007&amp;pages=2382-2388&amp;pmid=17332371&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib34">34. <span class="element-citation">Maggio EM, Stekelenburg E, Van den Berg A, Poppema S. TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. <span><span class="ref-journal">Int J Cancer. </span>2001;<span class="ref-vol">94</span>(1):60–66.</span> [<a href="/pubmed/11668479" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer.&amp;title=TP53+gene+mutations+in+Hodgkin+lymphoma+are+infrequent+and+not+associated+with+absence+of+Epstein-Barr+virus&amp;author=EM+Maggio&amp;author=E+Stekelenburg&amp;author=A+Van+den+Berg&amp;author=S+Poppema&amp;volume=94&amp;issue=1&amp;publication_year=2001&amp;pages=60-66&amp;pmid=11668479&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib35">35. <span class="element-citation">Gulley ML, Glaser SL, Craig FE, et al.  Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. <span><span class="ref-journal">Am J Clin Pathol. </span>2002;<span class="ref-vol">117</span>(2):259–267.</span> [<a href="/pubmed/11863222" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Pathol.&amp;title=Guidelines+for+interpreting+EBER+in+situ+hybridization+and+LMP1+immunohistochemical+tests+for+detecting+Epstein-Barr+virus+in+Hodgkin+lymphoma&amp;author=ML+Gulley&amp;author=SL+Glaser&amp;author=FE+Craig&amp;volume=117&amp;issue=2&amp;publication_year=2002&amp;pages=259-267&amp;pmid=11863222&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib36">36. <span class="element-citation">Wang D, Sun Y, Stang P, Berlin JA, Wilcox MA, Li Q. Comparison of methods for correcting population stratification in a genome-wide association study of rheumatoid arthritis: principal-component analysis versus multidimensional scaling. <span><span class="ref-journal">BMC Proc. </span>2009;<span class="ref-vol">3</span>(suppl 7):S109.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2795880/">PMC free article</a>]</span> [<a href="/pubmed/20017973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Proc.&amp;title=Comparison+of+methods+for+correcting+population+stratification+in+a+genome-wide+association+study+of+rheumatoid+arthritis:+principal-component+analysis+versus+multidimensional+scaling&amp;author=D+Wang&amp;author=Y+Sun&amp;author=P+Stang&amp;author=JA+Berlin&amp;author=MA+Wilcox&amp;volume=3&amp;issue=suppl+7&amp;publication_year=2009&amp;pages=S109&amp;pmid=20017973&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib37">37. <span class="element-citation">Deeks JJ, Altman DG, Bradburn MJ.  Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG, editors. <span class="ref-journal">Systematic Reviews in Health Care: Meta-analysis in Context.</span> London, UK: BMJ Publishing Group; 2001. pp. 285–312. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Systematic+Reviews+in+Health+Care:+Meta-analysis+in+Context&amp;author=JJ+Deeks&amp;author=DG+Altman&amp;author=MJ+Bradburn&amp;publication_year=2001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib38">38. <span class="element-citation">SAS Institute. <span class="ref-journal">SAS Statistical Software Version 9.</span> Cary, NC: SAS Institute; 2004.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=SAS+Statistical+Software+Version+9&amp;publication_year=2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib39">39. <span class="element-citation">de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>(R2):R122–R128.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2782358/">PMC free article</a>]</span> [<a href="/pubmed/18852200" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet.&amp;title=Practical+aspects+of+imputation-driven+meta-analysis+of+genome-wide+association+studies&amp;author=PI+de+Bakker&amp;author=MA+Ferreira&amp;author=X+Jia&amp;author=BM+Neale&amp;author=S+Raychaudhuri&amp;volume=17&amp;issue=R2&amp;publication_year=2008&amp;pages=R122-R128&amp;pmid=18852200&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib40">40. <span class="element-citation">Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1994;<span class="ref-vol">91</span>(14):6259–6263.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC44180/">PMC free article</a>]</span> [<a href="/pubmed/8022771" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A.&amp;title=A+second+lineage+of+mammalian+major+histocompatibility+complex+class+I+genes&amp;author=S+Bahram&amp;author=M+Bresnahan&amp;author=DE+Geraghty&amp;author=T+Spies&amp;volume=91&amp;issue=14&amp;publication_year=1994&amp;pages=6259-6263&amp;pmid=8022771&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib41">41. <span class="element-citation">Klitz W, Aldrich CL, Fildes N, Horning SJ, Begovich AB. Localization of predisposition to Hodgkin disease in the HLA class II region. <span><span class="ref-journal">Am J Hum Genet. </span>1994;<span class="ref-vol">54</span>(3):497–505.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1918115/">PMC free article</a>]</span> [<a href="/pubmed/8116619" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet.&amp;title=Localization+of+predisposition+to+Hodgkin+disease+in+the+HLA+class+II+region&amp;author=W+Klitz&amp;author=CL+Aldrich&amp;author=N+Fildes&amp;author=SJ+Horning&amp;author=AB+Begovich&amp;volume=54&amp;issue=3&amp;publication_year=1994&amp;pages=497-505&amp;pmid=8116619&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib42">42. <span class="element-citation">Oza AM, Tonks S, Lim J, Fleetwood MA, Lister TA, Bodmer JG. A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. <span><span class="ref-journal">Cancer Res. </span>1994;<span class="ref-vol">54</span>(19):5101–5105.</span> [<a href="/pubmed/7923125" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=A+clinical+and+epidemiological+study+of+human+leukocyte+antigen-DPB+alleles+in+Hodgkin's+disease&amp;author=AM+Oza&amp;author=S+Tonks&amp;author=J+Lim&amp;author=MA+Fleetwood&amp;author=TA+Lister&amp;volume=54&amp;issue=19&amp;publication_year=1994&amp;pages=5101-5105&amp;pmid=7923125&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib43">43. <span class="element-citation">Taylor GM, Gokhale DA. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype associated: response to Dorak, Mills, Poynton and Burnett. <span><span class="ref-journal">Leukemia. </span>1996;<span class="ref-vol">10</span>(11):1850–1851.</span> [<a href="/pubmed/8892697" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia.&amp;title=Increased+frequency+of+HLA-DPB1*0301+in+Hodgkin's+disease+suggests+that+susceptibility+is+HVR-sequence+and+subtype+associated:+response+to+Dorak,+Mills,+Poynton+and+Burnett&amp;author=GM+Taylor&amp;author=DA+Gokhale&amp;volume=10&amp;issue=11&amp;publication_year=1996&amp;pages=1850-1851&amp;pmid=8892697&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib44">44. <span class="element-citation">Taylor GM, Gokhale DA, Crowther D, et al.  Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. <span><span class="ref-journal">Br J Cancer. </span>1999;<span class="ref-vol">80</span>(9):1405–1411.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2363076/">PMC free article</a>]</span> [<a href="/pubmed/10424743" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Cancer.&amp;title=Further+investigation+of+the+role+of+HLA-DPB1+in+adult+Hodgkin's+disease+(HD)+suggests+an+influence+on+susceptibility+to+different+HD+subtypes&amp;author=GM+Taylor&amp;author=DA+Gokhale&amp;author=D+Crowther&amp;volume=80&amp;issue=9&amp;publication_year=1999&amp;pages=1405-1411&amp;pmid=10424743&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib45">45. <span class="element-citation">Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. <span><span class="ref-journal">J Clin Invest. </span>2005;<span class="ref-vol">115</span>(3):747–754.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC548315/">PMC free article</a>]</span> [<a href="/pubmed/15711639" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest.&amp;title=IL-13+R130Q,+a+common+variant+associated+with+allergy+and+asthma,+enhances+effector+mechanisms+essential+for+human+allergic+inflammation&amp;author=FD+Vladich&amp;author=SM+Brazille&amp;author=D+Stern&amp;author=ML+Peck&amp;author=R+Ghittoni&amp;volume=115&amp;issue=3&amp;publication_year=2005&amp;pages=747-754&amp;pmid=15711639&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib46">46. <span class="element-citation">Graves PE, Kabesch M, Halonen M, et al.  A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2000;<span class="ref-vol">105</span>(3):506–513.</span> [<a href="/pubmed/10719301" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol.&amp;title=A+cluster+of+seven+tightly+linked+polymorphisms+in+the+IL-13+gene+is+associated+with+total+serum+IgE+levels+in+three+populations+of+white+children&amp;author=PE+Graves&amp;author=M+Kabesch&amp;author=M+Halonen&amp;volume=105&amp;issue=3&amp;publication_year=2000&amp;pages=506-513&amp;pmid=10719301&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib47">47. <span class="element-citation">He JQ, Chan-Yeung M, Becker AB, et al.  Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. <span><span class="ref-journal">Genes Immun. </span>2003;<span class="ref-vol">4</span>(5):385–389.</span> [<a href="/pubmed/12847555" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Immun.&amp;title=Genetic+variants+of+the+IL13+and+IL4+genes+and+atopic+diseases+in+at-risk+children&amp;author=JQ+He&amp;author=M+Chan-Yeung&amp;author=AB+Becker&amp;volume=4&amp;issue=5&amp;publication_year=2003&amp;pages=385-389&amp;pmid=12847555&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib48">48. <span class="element-citation">Skinnider BF, Elia AJ, Gascoyne RD, et al.  Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. <span><span class="ref-journal">Blood. </span>2001;<span class="ref-vol">97</span>(1):250–255.</span> [<a href="/pubmed/11133768" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood.&amp;title=Interleukin+13+and+interleukin+13+receptor+are+frequently+expressed+by+Hodgkin+and+Reed-Sternberg+cells+of+Hodgkin+lymphoma&amp;author=BF+Skinnider&amp;author=AJ+Elia&amp;author=RD+Gascoyne&amp;volume=97&amp;issue=1&amp;publication_year=2001&amp;pages=250-255&amp;pmid=11133768&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib49">49. <span class="element-citation">Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. <span><span class="ref-journal">Blood. </span>2002;<span class="ref-vol">99</span>(12):4283–4297.</span> [<a href="/pubmed/12036854" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood.&amp;title=The+role+of+cytokines+in+classical+Hodgkin+lymphoma&amp;author=BF+Skinnider&amp;author=TW+Mak&amp;volume=99&amp;issue=12&amp;publication_year=2002&amp;pages=4283-4297&amp;pmid=12036854&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib50">50. <span class="element-citation">Ho IC, Tai TS, Pai SY. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. <span><span class="ref-journal">Nat Rev Immunol. </span>2009;<span class="ref-vol">9</span>(2):125–135.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2998182/">PMC free article</a>]</span> [<a href="/pubmed/19151747" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Immunol.&amp;title=GATA3+and+the+T-cell+lineage:+essential+functions+before+and+after+T-helper-2-cell+differentiation&amp;author=IC+Ho&amp;author=TS+Tai&amp;author=SY+Pai&amp;volume=9&amp;issue=2&amp;publication_year=2009&amp;pages=125-135&amp;pmid=19151747&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib51">51. <span class="element-citation">Stanelle J, Doring C, Hansmann ML, Kuppers R. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells. <span><span class="ref-journal">Blood. </span>2010;<span class="ref-vol">116</span>(20):4202–4211.</span> [<a href="/pubmed/20660789" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood.&amp;title=Mechanisms+of+aberrant+GATA3+expression+in+classical+Hodgkin+lymphoma+and+its+consequences+for+the+cytokine+profile+of+Hodgkin+and+Reed/Sternberg+cells&amp;author=J+Stanelle&amp;author=C+Doring&amp;author=ML+Hansmann&amp;author=R+Kuppers&amp;volume=116&amp;issue=20&amp;publication_year=2010&amp;pages=4202-4211&amp;pmid=20660789&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib52">52. <span class="element-citation">Monroy CM, Cortes AC, Lopez MS, et al.  Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes. <span><span class="ref-journal">Mol Carcinog. </span>2011;<span class="ref-vol">50</span>(1):36–46.</span> [<a href="/pubmed/21061265" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Carcinog.&amp;title=Hodgkin+disease+risk:+role+of+genetic+polymorphisms+and+gene-gene+interactions+in+inflammation+pathway+genes&amp;author=CM+Monroy&amp;author=AC+Cortes&amp;author=MS+Lopez&amp;volume=50&amp;issue=1&amp;publication_year=2011&amp;pages=36-46&amp;pmid=21061265&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib53">53. <span class="element-citation">Kraft P. Curses—winner's and otherwise—in genetic epidemiology. <span><span class="ref-journal">Epidemiology. </span>2008;<span class="ref-vol">19</span>(5):649–651.</span> discussion 657–648. [<a href="/pubmed/18703928" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epidemiology.&amp;title=Curses—winner's+and+otherwise—in+genetic+epidemiology&amp;author=P+Kraft&amp;volume=19&amp;issue=5&amp;publication_year=2008&amp;pages=649-651&amp;pmid=18703928&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib54">54. <span class="element-citation">Saveanu L, Carroll O, Lindo V, et al.  Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. <span><span class="ref-journal">Nat Immunol. </span>2005;<span class="ref-vol">6</span>(7):689–697.</span> [<a href="/pubmed/15908954" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Immunol.&amp;title=Concerted+peptide+trimming+by+human+ERAP1+and+ERAP2+aminopeptidase+complexes+in+the+endoplasmic+reticulum&amp;author=L+Saveanu&amp;author=O+Carroll&amp;author=V+Lindo&amp;volume=6&amp;issue=7&amp;publication_year=2005&amp;pages=689-697&amp;pmid=15908954&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib55">55. <span class="element-citation">Fruci D, Ferracuti S, Limongi MZ, et al.  Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">176</span>(8):4869–4879.</span> [<a href="/pubmed/16585582" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol.&amp;title=Expression+of+endoplasmic+reticulum+aminopeptidases+in+EBV-B+cell+lines+from+healthy+donors+and+in+leukemia/lymphoma,+carcinoma,+and+melanoma+cell+lines&amp;author=D+Fruci&amp;author=S+Ferracuti&amp;author=MZ+Limongi&amp;volume=176&amp;issue=8&amp;publication_year=2006&amp;pages=4869-4879&amp;pmid=16585582&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib56">56. <span class="element-citation">Landgren O, Engels EA, Pfeiffer RM, et al.  Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. <span><span class="ref-journal">J Natl Cancer Inst. </span>2006;<span class="ref-vol">98</span>(18):1321–1330.</span> [<a href="/pubmed/16985251" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst.&amp;title=Autoimmunity+and+susceptibility+to+Hodgkin+lymphoma:+a+population-based+case-control+study+in+Scandinavia&amp;author=O+Landgren&amp;author=EA+Engels&amp;author=RM+Pfeiffer&amp;volume=98&amp;issue=18&amp;publication_year=2006&amp;pages=1321-1330&amp;pmid=16985251&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib57">57. <span class="element-citation">Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. The risk of lymphoma in patients with psoriasis. <span><span class="ref-journal">J Invest Dermatol. </span>2006;<span class="ref-vol">126</span>(10):2194–2201.</span> [<a href="/pubmed/16741509" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol.&amp;title=The+risk+of+lymphoma+in+patients+with+psoriasis&amp;author=JM+Gelfand&amp;author=DB+Shin&amp;author=AL+Neimann&amp;author=X+Wang&amp;author=DJ+Margolis&amp;volume=126&amp;issue=10&amp;publication_year=2006&amp;pages=2194-2201&amp;pmid=16741509&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib58">58. <span class="element-citation">Dommasch E, Gelfand JM. Is there truly a risk of lymphoma from biologic therapies? <span><span class="ref-journal">Dermatol Ther. </span>2009;<span class="ref-vol">22</span>(5):418–430.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2768030/">PMC free article</a>]</span> [<a href="/pubmed/19845719" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dermatol+Ther.&amp;title=Is+there+truly+a+risk+of+lymphoma+from+biologic+therapies?&amp;author=E+Dommasch&amp;author=JM+Gelfand&amp;volume=22&amp;issue=5&amp;publication_year=2009&amp;pages=418-430&amp;pmid=19845719&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140214672096880title">Abstract</a></li><li><a href="#__sec11title">Methods</a></li><li><a href="#__sec18title">Results</a></li><li><a href="#__sec23title">Discussion</a></li><li><a href="#__sec24title">Funding</a></li><li><a href="#__sec25title">Supplementary Material</a></li><li><a href="#idm140214666748544title">Footnotes</a></li><li><a href="#idm140214669778640title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">JNCI Journal of the National Cancer Institute</span> are provided here courtesy of <strong>Oxford University Press</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3274508/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3274508/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3274508/pdf/djr516.pdf">PDF (1.0M)</a></li> | <li><a href="#" data-citationid="PMC3274508" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3274508%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3274508%2F&amp;text=Genome-Wide%20Association%20Study%20of%20Classical%20Hodgkin%20Lymphoma%20and%20Epstein%E2%80%93Barr%20Virus%20Status%E2%80%93Defined%20Subgroups" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3274508%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="22286212" data-aiid="3274508" data-aid="3274508" data-iid="205321" data-domainid="753" data-domain="jnci" data-accid="PMC3274508" data-md5="23881057160a0edc530f8e18f8b2770b">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-5" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input name="absid" id="absid" value="3274508" type="hidden"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" value="1" type="submit"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-6" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-6" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/25648508" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.</a><span class="source">[Int J Cancer. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Johnson PC, McAulay KA, Montgomery D, Lake A, Shield L, Gallagher A, Little AM, Shah A, Marsh SG, Taylor GM, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Cancer. 2015 Sep 1; 137(5):1066-75. Epub 2015 Feb 20.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/26404960" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma.</a><span class="source">[Cancer Epidemiol Biomarkers Pr...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Delahaye-Sourdeix M, Urayama KY, Gaborieau V, Veenstra R, Foll M, Chabrier A, Benavente Y, Nieters A, Becker N, Foretova L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cancer Epidemiol Biomarkers Prev. 2015 Dec; 24(12):1838-43. Epub 2015 Sep 24.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/26261988" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.</a><span class="source">[PLoS One. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Martín P, Krsnik I, Navarro B, Provencio M, García JF, Bellas C, Vilches C, Gomez-Lozano N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS One. 2015; 10(8):e0135512. Epub 2015 Aug 11.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/26189878" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Human leukocyte antigens and genetic susceptibility to lymphoma.</a><span class="source">[Tissue Antigens. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McAulay KA, Jarrett RF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Tissue Antigens. 2015 Aug; 86(2):98-113. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/23788758" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).</a><span class="source">[Ann Oncol. 2013]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-11" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kamper-Jørgensen M, Rostgaard K, Glaser SL, Zahm SH, Cozen W, Smedby KE, Sanjosé S, Chang ET, Zheng T, La Vecchia C, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Oncol. 2013 Sep; 24(9):2245-55. Epub 2013 Jun 19.</em>
</div>
</li>
</ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=22286212&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=22286212&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-12" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-12" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6822543/" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Assessment of rosacea symptom severity by genome-wide association study and expression analysis highlights immuno-inflammatory and skin pigmentation genes</a><span class="source">[Human Molecular Genetics. 2018]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Aponte JL, Chiano MN, Yerges-Armstrong LM, Hinds DA, Tian C, Gupta A, Guo C, Fraser DJ, Freudenberg JM, Rajpal DK, Ehm MG, Waterworth DM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Human Molecular Genetics. 2018 May 16; 27(15): 2762-2772</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6790270/" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study</a><span class="source">[The Lancet. Oncology. 2016]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Li Z, Xia Y, Feng LN, Chen JR, Li HM, Cui J, Cai QQ, Sim KS, Nairismägi ML, Laurensia Y, Meah WY, Liu WS, Guo YM, Chen LZ, Feng QS, Pang CP, Chen LJ, Chew SH, Ebstein RP, Foo JN, Liu J, Ha J, Khoo LP, Chin ST, Zeng YX, Aung T, Chowbay B, Diong CP, Zhang F, Liu YH, Tang T, Tao M, Quek R, Mohamad F, Tan SY, Teh BT, Ng SB, Chng WJ, Ong CK, Okada Y, Raychaudhuri S, Lim ST, Tan W, Peng RJ, Khor CC, Bei JX. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">The Lancet. Oncology. 2016 Jul 25; 17(9): 1240-1247</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6753923/" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Identification of lncRNAs associated with lung squamous cell carcinoma prognosis in the competitive endogenous RNA network</a><span class="source">[PeerJ. 2019]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Qi L, Zhang T, Yao Y, Zhuang J, Liu C, Liu R, Sun C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PeerJ. 2019 Sep 17; 7: e7727</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6659368/" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Elucidation of causal direction between asthma and obesity: a bi-directional Mendelian randomization study</a><span class="source">[International Journal of Epide...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Xu S, Gilliland FD, Conti DV. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">International Journal of Epidemiology. 2019 Apr 21; 48(3): 899-907</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6236462/" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma</a><span class="source">[Blood. 2018]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-17" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sud A, Thomsen H, Orlando G, Försti A, Law PJ, Broderick P, Cooke R, Hariri F, Pastinen T, Easton DF, Pharoah PD, Dunning AM, Peto J, Canzian F, Eeles R, Kote-Jarai Z, Muir K, Pashayan N, Campa D, the PRACTICAL Consortium, Hoffmann P, Nöthen MM, Jöckel KH, von Strandmann EP, Swerdlow AJ, Engert A, Orr N, Hemminki K, Houlston RS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Blood. 2018 Nov 8; 132(19): 2040-2052</em>
</div>
</li>
</ul>
<a class="seemore" href="citedby/" ref="reftype=relart&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-18" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-18" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene&amp;IdsFromResult=3274508" ref="reftype=Gene&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Gene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene<div class="brieflinkpopdesc">Gene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=geoprofiles&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_geoprofiles&amp;IdsFromResult=3274508" ref="reftype=GEO%20Profiles&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">GEO Profiles</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">GEO Profiles<div class="brieflinkpopdesc">Related GEO records</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=homologene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_homologene&amp;IdsFromResult=3274508" ref="reftype=HomoloGene&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|HomoloGene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">HomoloGene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-21" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">HomoloGene<div class="brieflinkpopdesc">HomoloGene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3274508" ref="reftype=MedGen&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-22" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pubmed/22286212/" ref="reftype=PubMed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-23" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=snp&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_snp&amp;IdsFromResult=3274508" ref="reftype=SNP&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|SNP&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">SNP</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-24" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">SNP<div class="brieflinkpopdesc">PMC to SNP links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=3274508" ref="reftype=Substance&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-25" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=3274508" ref="reftype=Taxonomy&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Taxonomy</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-26" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter shutter_closed ui-ncbitoggler" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-27" role="button" aria-expanded="false" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave" style="display: none;" id="ui-portlet_content-27" aria-hidden="true"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dd53f3175f66d018fe90243">Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Vir...</a><div class="ralinkpop offscreen_noflow">Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups<div class="brieflinkpopdesc">JNCI Journal of the National Cancer Institute. 2012 Feb 8; 104(3)240</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=5dd53f0ddde0893a8b018a53">Evaluation of published single nucleotide polymorphisms associated with acute GV...</a><div class="ralinkpop offscreen_noflow">Evaluation of published single nucleotide polymorphisms associated with acute GVHD<div class="brieflinkpopdesc">Blood. 2012 May 31; 119(22)5311</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=5dd53edf75f66d018fdb08bf">Discovery of common variants associated with low TSH levels and thyroid cancer r...</a><div class="ralinkpop offscreen_noflow">Discovery of common variants associated with low TSH levels and thyroid cancer risk<div class="brieflinkpopdesc">NIHPA Author Manuscripts. ; 44(3)319</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=5dd53ec575f66d018fd68d26">A large scale multivariate parallel ICA method reveals novel imaging-genetic rel...</a><div class="ralinkpop offscreen_noflow">A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer’s Disease in the ADNI cohort<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2012 Apr 15; 60(3)1608</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=5dd53e9239a66eb03dce0a0a">Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Asso...</a><div class="ralinkpop offscreen_noflow">Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2012 Mar 1; 72(5)1182</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p12" name="crb--__p12" rid="__p12" style="position: absolute; visibility: visible; width: 370px; top: 2403px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul><li class="two_line" reference_id="bib3">
<a href="/pubmed/19078975/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The biology of Hodgkin's lymphoma.</a><span class="one_line_source">[Nat Rev Cancer.  2009]</span><div class="alt-note">
<div class="authors">Küppers R</div>
<div class="citation">Nat Rev Cancer. 2009 Jan; 9(1):15-27.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p13" name="crb--__p13" rid="__p13" style="position: absolute; visibility: visible; width: 370px; top: 2568px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="bib4">
<a href="/pubmed/9705682/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997.</a><span class="one_line_source">[IARC Monogr Eval Carcinog Risks Hum.  1997]</span><div class="alt-note">
<div class="authors"></div>
<div class="citation">IARC Monogr Eval Carcinog Risks Hum. 1997; 70():1-492.</div>
</div>
</li>
<li class="two_line" reference_id="bib5">
<a href="/pubmed/8123850/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity.</a><span class="one_line_source">[Blood.  1994]</span><div class="alt-note">
<div class="authors">Gulley ML, Eagan PA, Quintanilla-Martinez L, Picado AL, Smir BN, Childs C, Dunn CD, Craig FE, Williams JW Jr, Banks PM</div>
<div class="citation">Blood. 1994 Mar 15; 83(6):1595-602.</div>
</div>
</li>
<li class="two_line" reference_id="bib6">
<a href="/pubmed/14600123/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates.</a><span class="one_line_source">[J Clin Pathol.  2003]</span><div class="alt-note">
<div class="authors">Jarrett RF, Krajewski AS, Angus B, Freeland J, Taylor PR, Taylor GM, Alexander FE</div>
<div class="citation">J Clin Pathol. 2003 Nov; 56(11):811-6.</div>
</div>
</li>
<li class="two_line" reference_id="bib7">
<a href="/pubmed/9033642/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.</a><span class="one_line_source">[Int J Cancer.  1997]</span><div class="alt-note">
<div class="authors">Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O'Grady J, Hummel M, Preciado MV, Knecht H, Chan JK, Claviez A</div>
<div class="citation">Int J Cancer. 1997 Feb 7; 70(4):375-82.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p14" name="crb--__p14" rid="__p14" style="position: absolute; visibility: visible; width: 370px; top: 2799px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="bib8">
<a href="/pubmed/15978930/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.</a><span class="one_line_source">[Lancet.  2005]</span><div class="alt-note">
<div class="authors">Diepstra A, Niens M, Vellenga E, van Imhoff GW, Nolte IM, Schaapveld M, van der Steege G, van den Berg A, Kibbelaar RE, te Meerman GJ, Poppema S</div>
<div class="citation">Lancet. 2005 Jun 25-Jul 1; 365(9478):2216-24.</div>
</div>
</li>
<li class="two_line" reference_id="bib9">
<a href="/pubmed/20308568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2010]</span><div class="alt-note">
<div class="authors">Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF</div>
<div class="citation">Proc Natl Acad Sci U S A. 2010 Apr 6; 107(14):6400-5.</div>
</div>
</li>
<li class="two_line" reference_id="bib10">
<a href="/pubmed/17630352/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.</a><span class="one_line_source">[Blood.  2007]</span><div class="alt-note">
<div class="authors">Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, Kouprie N, Delury CP, Gallagher A, Visser L, Poppema S, te Meerman GJ, van den Berg A</div>
<div class="citation">Blood. 2007 Nov 1; 110(9):3310-5.</div>
</div>
</li>
<li class="two_line" reference_id="bib11">
<a href="/pubmed/21037568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, van den Berg A, Olver B, Lloyd A, Dobbins SE, Lightfoot T, van Leeuwen FE, Försti A, Diepstra A, Broeks A, Vijayakrishnan J, Shield L, Lake A, Montgomery D, Roman E, Engert A, von Strandmann EP, Reiners KS, Nolte IM, Smedby KE, Adami HO, Russell NS, Glimelius B, Hamilton-Dutoit S, de Bruin M, Ryder LP, Molin D, Sorensen KM, Chang ET, Taylor M, Cooke R, Hofstra R, Westers H, van Wezel T, van Eijk R, Ashworth A, Rostgaard K, Melbye M, Swerdlow AJ, Houlston RS</div>
<div class="citation">Nat Genet. 2010 Dec; 42(12):1126-1130.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p16" name="crb--__p16" rid="__p16" style="position: absolute; visibility: visible; width: 370px; top: 3279px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul>
<li class="two_line" reference_id="bib12">
<a href="/pubmed/16819547/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH).</a><span class="one_line_source">[Br J Cancer.  2006]</span><div class="alt-note">
<div class="authors">Besson H, Brennan P, Becker N, De Sanjosé S, Nieters A, Font R, Maynadié M, Foretova L, Cocco PL, Staines A, Vornanen M, Boffetta P</div>
<div class="citation">Br J Cancer. 2006 Aug 7; 95(3):378-84.</div>
</div>
</li>
<li class="two_line" reference_id="bib6">
<a href="/pubmed/14600123/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates.</a><span class="one_line_source">[J Clin Pathol.  2003]</span><div class="alt-note">
<div class="authors">Jarrett RF, Krajewski AS, Angus B, Freeland J, Taylor PR, Taylor GM, Alexander FE</div>
<div class="citation">J Clin Pathol. 2003 Nov; 56(11):811-6.</div>
</div>
</li>
<li class="two_line" reference_id="bib9">
<a href="/pubmed/20308568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2010]</span><div class="alt-note">
<div class="authors">Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF</div>
<div class="citation">Proc Natl Acad Sci U S A. 2010 Apr 6; 107(14):6400-5.</div>
</div>
</li>
<li class="two_line" reference_id="bib13">
<a href="/pubmed/12949811/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults.</a><span class="one_line_source">[Int J Cancer.  2003]</span><div class="alt-note">
<div class="authors">Alexander FE, Lawrence DJ, Freeland J, Krajewski AS, Angus B, Taylor GM, Jarrett RF</div>
<div class="citation">Int J Cancer. 2003 Nov 1; 107(2):298-302.</div>
</div>
</li>
<li class="two_line" reference_id="bib14">
<a href="/pubmed/15687363/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Ultraviolet radiation exposure and risk of malignant lymphomas.</a><span class="one_line_source">[J Natl Cancer Inst.  2005]</span><div class="alt-note">
<div class="authors">Smedby KE, Hjalgrim H, Melbye M, Torrång A, Rostgaard K, Munksgaard L, Adami J, Hansen M, Porwit-MacDonald A, Jensen BA, Roos G, Pedersen BB, Sundström C, Glimelius B, Adami HO</div>
<div class="citation">J Natl Cancer Inst. 2005 Feb 2; 97(3):199-209.</div>
</div>
</li>
<li class="two_line" reference_id="bib8">
<a href="/pubmed/15978930/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.</a><span class="one_line_source">[Lancet.  2005]</span><div class="alt-note">
<div class="authors">Diepstra A, Niens M, Vellenga E, van Imhoff GW, Nolte IM, Schaapveld M, van der Steege G, van den Berg A, Kibbelaar RE, te Meerman GJ, Poppema S</div>
<div class="citation">Lancet. 2005 Jun 25-Jul 1; 365(9478):2216-24.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p21" name="crb--__p21" rid="__p21" style="position: absolute; visibility: visible; width: 370px; top: 4849px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="bib15">
<a href="/pubmed/18830131/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection.</a><span class="one_line_source">[Eur J Cancer Prev.  2009]</span><div class="alt-note">
<div class="authors">Lagiou P, Georgila C, Minaki P, Ahrens W, Pohlabeln H, Benhamou S, Bouchardy C, Slamova A, Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Castellsague X, Macfarlane TV, Macfarlane GJ, Talamini R, Barzan L, Canova C, Simonato L, Lowry R, Conway DI, McKinney PA, Znaor A, McCartan BE, Healy C, Nelis M, Metspalu A, Marron M, Hashibe M, Brennan PJ</div>
<div class="citation">Eur J Cancer Prev. 2009 Feb; 18(1):76-84.</div>
</div>
</li>
<li class="two_line" reference_id="bib16">
<a href="/pubmed/18500343/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Multiple ADH genes are associated with upper aerodigestive cancers.</a><span class="one_line_source">[Nat Genet.  2008]</span><div class="alt-note">
<div class="authors">Hashibe M, McKay JD, Curado MP, Oliveira JC, Koifman S, Koifman R, Zaridze D, Shangina O, Wünsch-Filho V, Eluf-Neto J, Levi JE, Matos E, Lagiou P, Lagiou A, Benhamou S, Bouchardy C, Szeszenia-Dabrowska N, Menezes A, Dall'Agnol MM, Merletti F, Richiardi L, Fernandez L, Lence J, Talamini R, Barzan L, Mates D, Mates IN, Kjaerheim K, Macfarlane GJ, Macfarlane TV, Simonato L, Canova C, Holcátová I, Agudo A, Castellsagué X, Lowry R, Janout V, Kollarova H, Conway DI, McKinney PA, Znaor A, Fabianova E, Bencko V, Lissowska J, Chabrier A, Hung RJ, Gaborieau V, Boffetta P, Brennan P</div>
<div class="citation">Nat Genet. 2008 Jun; 40(6):707-9.</div>
</div>
</li>
<li class="two_line" reference_id="bib17">
<a href="/pubmed/19648918/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.</a><span class="one_line_source">[Nat Genet.  2009]</span><div class="alt-note">
<div class="authors">Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW Jr, Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN</div>
<div class="citation">Nat Genet. 2009 Sep; 41(9):986-90.</div>
</div>
</li>
<li class="two_line" reference_id="bib18" style="display: none;">
<a href="/pubmed/17568781/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study.</a><span class="one_line_source">[Kidney Int.  2007]</span><div class="alt-note">
<div class="authors">Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M</div>
<div class="citation">Kidney Int. 2007 Sep; 72(5):632-7.</div>
</div>
</li>
<li class="two_line" reference_id="bib19" style="display: none;">
<a href="/pubmed/10645817/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Health problems in teenage daily smokers versus nonsmokers, Norway, 1995-1997: the Nord-Trøndelag Health Study.</a><span class="one_line_source">[Am J Epidemiol.  2000]</span><div class="alt-note">
<div class="authors">Holmen TL, Barrett-Connor E, Holmen J, Bjermer L</div>
<div class="citation">Am J Epidemiol. 2000 Jan 15; 151(2):148-55.</div>
</div>
</li>
<li class="two_line" reference_id="bib20" style="display: none;">
<a href="/pubmed/17653600/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolic risk factors associated with serum creatinine in a non-diabetic population.</a><span class="one_line_source">[Eur J Epidemiol.  2007]</span><div class="alt-note">
<div class="authors">Kronborg J, Jenssen T, Njølstad I, Toft I, Eriksen BO</div>
<div class="citation">Eur J Epidemiol. 2007; 22(10):707-13.</div>
</div>
</li>
<li class="two_line" reference_id="bib21" style="display: none;">
<a href="/pubmed/17554300/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.</a><span class="one_line_source">[Nature.  2007]</span><div class="alt-note">
<div class="authors">Wellcome Trust Case Control Consortium.</div>
<div class="citation">Nature. 2007 Jun 7; 447(7145):661-78.</div>
</div>
</li>
</ul><a href="" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p22" name="crb--__p22" rid="__p22" style="position: absolute; visibility: visible; width: 370px; top: 5055px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul><li class="two_line" reference_id="bib22">
<a href="/pubmed/21131975/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.</a><span class="one_line_source">[Nat Genet.  2011]</span><div class="alt-note">
<div class="authors">Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, Prokhortchouk E, Wu X, Kiemeney LA, Gaborieau V, Jacobs KB, Chow WH, Zaridze D, Matveev V, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Bucur A, Bencko V, Foretova L, Janout V, Boffetta P, Colt JS, Davis FG, Schwartz KL, Banks RE, Selby PJ, Harnden P, Berg CD, Hsing AW, Grubb RL 3rd, Boeing H, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, Duell EJ, Quirós JR, Sanchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Khaw KT, Allen NE, Bueno-de-Mesquita HB, Peeters PH, Trichopoulos D, Linseisen J, Ljungberg B, Overvad K, Tjønneland A, Romieu I, Riboli E, Mukeria A, Shangina O, Stevens VL, Thun MJ, Diver WR, Gapstur SM, Pharoah PD, Easton DF, Albanes D, Weinstein SJ, Virtamo J, Vatten L, Hveem K, Njølstad I, Tell GS, Stoltenberg C, Kumar R, Koppova K, Cussenot O, Benhamou S, Oosterwijk E, Vermeulen SH, Aben KK, van der Marel SL, Ye Y, Wood CG, Pu X, Mazur AM, Boulygina ES, Chekanov NN, Foglio M, Lechner D, Gut I, Heath S, Blanche H, Hutchinson A, Thomas G, Wang Z, Yeager M, Fraumeni JF Jr, Skryabin KG, McKay JD, Rothman N, Chanock SJ, Lathrop M, Brennan P</div>
<div class="citation">Nat Genet. 2011 Jan; 43(1):60-5.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p24" name="crb--__p24" rid="__p24">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul><li class="expanded" reference_id="bib23">
<a href="/pubmed/17701901/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PLINK: a tool set for whole-genome association and population-based linkage analyses.</a><span class="one_line_source">[Am J Hum Genet.  2007]</span><div class="alt-note">
<div class="authors">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC</div>
<div class="citation">Am J Hum Genet. 2007 Sep; 81(3):559-75.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p25" name="crb--__p25" rid="__p25">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul>
<li class="expanded" reference_id="bib24">
<a href="/pubmed/18596976/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Population substructure and control selection in genome-wide association studies.</a><span class="one_line_source">[PLoS One.  2008]</span><div class="alt-note">
<div class="authors">Yu K, Wang Z, Li Q, Wacholder S, Hunter DJ, Hoover RN, Chanock S, Thomas G</div>
<div class="citation">PLoS One. 2008 Jul 2; 3(7):e2551.</div>
</div>
</li>
<li class="expanded" reference_id="bib25">
<a href="/pubmed/16862161/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Principal components analysis corrects for stratification in genome-wide association studies.</a><span class="one_line_source">[Nat Genet.  2006]</span><div class="alt-note">
<div class="authors">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D</div>
<div class="citation">Nat Genet. 2006 Aug; 38(8):904-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p27" name="crb--__p27" rid="__p27">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul>
<li class="expanded" reference_id="bib12">
<a href="/pubmed/16819547/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH).</a><span class="one_line_source">[Br J Cancer.  2006]</span><div class="alt-note">
<div class="authors">Besson H, Brennan P, Becker N, De Sanjosé S, Nieters A, Font R, Maynadié M, Foretova L, Cocco PL, Staines A, Vornanen M, Boffetta P</div>
<div class="citation">Br J Cancer. 2006 Aug 7; 95(3):378-84.</div>
</div>
</li>
<li class="expanded" reference_id="bib6">
<a href="/pubmed/14600123/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates.</a><span class="one_line_source">[J Clin Pathol.  2003]</span><div class="alt-note">
<div class="authors">Jarrett RF, Krajewski AS, Angus B, Freeland J, Taylor PR, Taylor GM, Alexander FE</div>
<div class="citation">J Clin Pathol. 2003 Nov; 56(11):811-6.</div>
</div>
</li>
<li class="expanded" reference_id="bib9">
<a href="/pubmed/20308568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2010]</span><div class="alt-note">
<div class="authors">Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF</div>
<div class="citation">Proc Natl Acad Sci U S A. 2010 Apr 6; 107(14):6400-5.</div>
</div>
</li>
<li class="expanded" reference_id="bib13">
<a href="/pubmed/12949811/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults.</a><span class="one_line_source">[Int J Cancer.  2003]</span><div class="alt-note">
<div class="authors">Alexander FE, Lawrence DJ, Freeland J, Krajewski AS, Angus B, Taylor GM, Jarrett RF</div>
<div class="citation">Int J Cancer. 2003 Nov 1; 107(2):298-302.</div>
</div>
</li>
<li class="expanded" reference_id="bib26">
<a href="/pubmed/17099321/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Does smoking or alcohol modify the risk of Epstein-Barr virus-positive or -negative Hodgkin lymphoma?</a><span class="one_line_source">[Epidemiology.  2007]</span><div class="alt-note">
<div class="authors">Willett EV, O'Connor S, Smith AG, Roman E</div>
<div class="citation">Epidemiology. 2007 Jan; 18(1):130-6.</div>
</div>
</li>
<li class="expanded" reference_id="bib31">
<a href="/pubmed/20953190/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Genetic Analysis of Psoriasis Consortium &amp; the Wellcome Trust Case Control Consortium 2., Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, Bergboer JG, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Cork MJ, Corvin A, Deloukas P, Dilthey A, Duncanson A, Edkins S, Estivill X, Fitzgerald O, Freeman C, Giardina E, Gray E, Hofer A, Hüffmeier U, Hunt SE, Irvine AD, Jankowski J, Kirby B, Langford C, Lascorz J, Leman J, Leslie S, Mallbris L, Markus HS, Mathew CG, McLean WH, McManus R, Mössner R, Moutsianas L, Naluai AT, Nestle FO, Novelli G, Onoufriadis A, Palmer CN, Perricone C, Pirinen M, Plomin R, Potter SC, Pujol RM, Rautanen A, Riveira-Munoz E, Ryan AW, Salmhofer W, Samuelsson L, Sawcer SJ, Schalkwijk J, Smith CH, Ståhle M, Su Z, Tazi-Ahnini R, Traupe H, Viswanathan AC, Warren RB, Weger W, Wolk K, Wood N, Worthington J, Young HS, Zeeuwen PL, Hayday A, Burden AD, Griffiths CE, Kere J, Reis A, McVean G, Evans DM, Brown MA, Barker JN, Peltonen L, Donnelly P, Trembath RC</div>
<div class="citation">Nat Genet. 2010 Nov; 42(11):985-90.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p29" name="crb--__p29" rid="__p29">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul>
<li class="expanded" reference_id="bib32">
<a href="/pubmed/9697883/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis.</a><span class="one_line_source">[Leukemia.  1998]</span><div class="alt-note">
<div class="authors">Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF</div>
<div class="citation">Leukemia. 1998 Aug; 12(8):1272-6.</div>
</div>
</li>
<li class="expanded" reference_id="bib34">
<a href="/pubmed/11668479/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus.</a><span class="one_line_source">[Int J Cancer.  2001]</span><div class="alt-note">
<div class="authors">Maggio EM, Stekelenburg E, Van den Berg A, Poppema S</div>
<div class="citation">Int J Cancer. 2001 Oct 1; 94(1):60-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p30" name="crb--__p30" rid="__p30">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul><li class="expanded" reference_id="bib35">
<a href="/pubmed/11863222/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.</a><span class="one_line_source">[Am J Clin Pathol.  2002]</span><div class="alt-note">
<div class="authors">Gulley ML, Glaser SL, Craig FE, Borowitz M, Mann RB, Shema SJ, Ambinder RF</div>
<div class="citation">Am J Clin Pathol. 2002 Feb; 117(2):259-67.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p31" name="crb--__p31" rid="__p31">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul>
<li class="expanded" reference_id="bib36">
<a href="/pubmed/20017973/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison of methods for correcting population stratification in a genome-wide association study of rheumatoid arthritis: principal-component analysis versus multidimensional scaling.</a><span class="one_line_source">[BMC Proc.  2009]</span><div class="alt-note">
<div class="authors">Wang D, Sun Y, Stang P, Berlin JA, Wilcox MA, Li Q</div>
<div class="citation">BMC Proc. 2009 Dec 15; 3 Suppl 7():S109.</div>
</div>
</li>
<li class="expanded" reference_id="bib21">
<a href="/pubmed/17554300/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.</a><span class="one_line_source">[Nature.  2007]</span><div class="alt-note">
<div class="authors">Wellcome Trust Case Control Consortium.</div>
<div class="citation">Nature. 2007 Jun 7; 447(7145):661-78.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p32" name="crb--__p32" rid="__p32">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul><li class="expanded" reference_id="bib23">
<a href="/pubmed/17701901/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PLINK: a tool set for whole-genome association and population-based linkage analyses.</a><span class="one_line_source">[Am J Hum Genet.  2007]</span><div class="alt-note">
<div class="authors">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC</div>
<div class="citation">Am J Hum Genet. 2007 Sep; 81(3):559-75.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p33" name="crb--__p33" rid="__p33">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-41"><ul><li class="expanded" reference_id="bib39">
<a href="/pubmed/18852200/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Practical aspects of imputation-driven meta-analysis of genome-wide association studies.</a><span class="one_line_source">[Hum Mol Genet.  2008]</span><div class="alt-note">
<div class="authors">de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF</div>
<div class="citation">Hum Mol Genet. 2008 Oct 15; 17(R2):R122-8.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p42" name="crb--__p42" rid="__p42">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-42"><ul><li class="expanded" reference_id="bib9">
<a href="/pubmed/20308568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2010]</span><div class="alt-note">
<div class="authors">Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF</div>
<div class="citation">Proc Natl Acad Sci U S A. 2010 Apr 6; 107(14):6400-5.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p43" name="crb--__p43" rid="__p43">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-43"><ul><li class="expanded" reference_id="bib11">
<a href="/pubmed/21037568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, van den Berg A, Olver B, Lloyd A, Dobbins SE, Lightfoot T, van Leeuwen FE, Försti A, Diepstra A, Broeks A, Vijayakrishnan J, Shield L, Lake A, Montgomery D, Roman E, Engert A, von Strandmann EP, Reiners KS, Nolte IM, Smedby KE, Adami HO, Russell NS, Glimelius B, Hamilton-Dutoit S, de Bruin M, Ryder LP, Molin D, Sorensen KM, Chang ET, Taylor M, Cooke R, Hofstra R, Westers H, van Wezel T, van Eijk R, Ashworth A, Rostgaard K, Melbye M, Swerdlow AJ, Houlston RS</div>
<div class="citation">Nat Genet. 2010 Dec; 42(12):1126-1130.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p44" name="crb--__p44" rid="__p44">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-44"><ul><li class="expanded" reference_id="bib31">
<a href="/pubmed/20953190/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Genetic Analysis of Psoriasis Consortium &amp; the Wellcome Trust Case Control Consortium 2., Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, Bergboer JG, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Cork MJ, Corvin A, Deloukas P, Dilthey A, Duncanson A, Edkins S, Estivill X, Fitzgerald O, Freeman C, Giardina E, Gray E, Hofer A, Hüffmeier U, Hunt SE, Irvine AD, Jankowski J, Kirby B, Langford C, Lascorz J, Leman J, Leslie S, Mallbris L, Markus HS, Mathew CG, McLean WH, McManus R, Mössner R, Moutsianas L, Naluai AT, Nestle FO, Novelli G, Onoufriadis A, Palmer CN, Perricone C, Pirinen M, Plomin R, Potter SC, Pujol RM, Rautanen A, Riveira-Munoz E, Ryan AW, Salmhofer W, Samuelsson L, Sawcer SJ, Schalkwijk J, Smith CH, Ståhle M, Su Z, Tazi-Ahnini R, Traupe H, Viswanathan AC, Warren RB, Weger W, Wolk K, Wood N, Worthington J, Young HS, Zeeuwen PL, Hayday A, Burden AD, Griffiths CE, Kere J, Reis A, McVean G, Evans DM, Brown MA, Barker JN, Peltonen L, Donnelly P, Trembath RC</div>
<div class="citation">Nat Genet. 2010 Nov; 42(11):985-90.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p58" name="crb--__p58" rid="__p58">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-45"><ul>
<li class="expanded" reference_id="bib40">
<a href="/pubmed/8022771/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A second lineage of mammalian major histocompatibility complex class I genes.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  1994]</span><div class="alt-note">
<div class="authors">Bahram S, Bresnahan M, Geraghty DE, Spies T</div>
<div class="citation">Proc Natl Acad Sci U S A. 1994 Jul 5; 91(14):6259-63.</div>
</div>
</li>
<li class="expanded" reference_id="bib8">
<a href="/pubmed/15978930/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.</a><span class="one_line_source">[Lancet.  2005]</span><div class="alt-note">
<div class="authors">Diepstra A, Niens M, Vellenga E, van Imhoff GW, Nolte IM, Schaapveld M, van der Steege G, van den Berg A, Kibbelaar RE, te Meerman GJ, Poppema S</div>
<div class="citation">Lancet. 2005 Jun 25-Jul 1; 365(9478):2216-24.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p59" name="crb--__p59" rid="__p59">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-46"><ul>
<li class="expanded" reference_id="bib9">
<a href="/pubmed/20308568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2010]</span><div class="alt-note">
<div class="authors">Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF</div>
<div class="citation">Proc Natl Acad Sci U S A. 2010 Apr 6; 107(14):6400-5.</div>
</div>
</li>
<li class="expanded" reference_id="bib10">
<a href="/pubmed/17630352/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.</a><span class="one_line_source">[Blood.  2007]</span><div class="alt-note">
<div class="authors">Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, Kouprie N, Delury CP, Gallagher A, Visser L, Poppema S, te Meerman GJ, van den Berg A</div>
<div class="citation">Blood. 2007 Nov 1; 110(9):3310-5.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p60" name="crb--__p60" rid="__p60">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-47"><ul>
<li class="expanded" reference_id="bib11">
<a href="/pubmed/21037568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, van den Berg A, Olver B, Lloyd A, Dobbins SE, Lightfoot T, van Leeuwen FE, Försti A, Diepstra A, Broeks A, Vijayakrishnan J, Shield L, Lake A, Montgomery D, Roman E, Engert A, von Strandmann EP, Reiners KS, Nolte IM, Smedby KE, Adami HO, Russell NS, Glimelius B, Hamilton-Dutoit S, de Bruin M, Ryder LP, Molin D, Sorensen KM, Chang ET, Taylor M, Cooke R, Hofstra R, Westers H, van Wezel T, van Eijk R, Ashworth A, Rostgaard K, Melbye M, Swerdlow AJ, Houlston RS</div>
<div class="citation">Nat Genet. 2010 Dec; 42(12):1126-1130.</div>
</div>
</li>
<li class="expanded" reference_id="bib41">
<a href="/pubmed/8116619/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Localization of predisposition to Hodgkin disease in the HLA class II region.</a><span class="one_line_source">[Am J Hum Genet.  1994]</span><div class="alt-note">
<div class="authors">Klitz W, Aldrich CL, Fildes N, Horning SJ, Begovich AB</div>
<div class="citation">Am J Hum Genet. 1994 Mar; 54(3):497-505.</div>
</div>
</li>
<li class="expanded" reference_id="bib44">
<a href="/pubmed/10424743/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes.</a><span class="one_line_source">[Br J Cancer.  1999]</span><div class="alt-note">
<div class="authors">Taylor GM, Gokhale DA, Crowther D, Woll PJ, Harris M, Ryder D, Ayres M, Radford JA</div>
<div class="citation">Br J Cancer. 1999 Jul; 80(9):1405-11.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p61" name="crb--__p61" rid="__p61">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-48"><ul>
<li class="expanded" reference_id="bib45">
<a href="/pubmed/15711639/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.</a><span class="one_line_source">[J Clin Invest.  2005]</span><div class="alt-note">
<div class="authors">Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D</div>
<div class="citation">J Clin Invest. 2005 Mar; 115(3):747-54.</div>
</div>
</li>
<li class="expanded" reference_id="bib46">
<a href="/pubmed/10719301/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children.</a><span class="one_line_source">[J Allergy Clin Immunol.  2000]</span><div class="alt-note">
<div class="authors">Graves PE, Kabesch M, Halonen M, Holberg CJ, Baldini M, Fritzsch C, Weiland SK, Erickson RP, von Mutius E, Martinez FD</div>
<div class="citation">J Allergy Clin Immunol. 2000 Mar; 105(3):506-13.</div>
</div>
</li>
<li class="expanded" reference_id="bib47">
<a href="/pubmed/12847555/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children.</a><span class="one_line_source">[Genes Immun.  2003]</span><div class="alt-note">
<div class="authors">He JQ, Chan-Yeung M, Becker AB, Dimich-Ward H, Ferguson AC, Manfreda J, Watson WT, Sandford AJ</div>
<div class="citation">Genes Immun. 2003 Jul; 4(5):385-9.</div>
</div>
</li>
<li class="expanded" reference_id="bib28">
<a href="/pubmed/20159242/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions.</a><span class="one_line_source">[J Allergy Clin Immunol.  2010]</span><div class="alt-note">
<div class="authors">Li X, Howard TD, Zheng SL, Haselkorn T, Peters SP, Meyers DA, Bleecker ER</div>
<div class="citation">J Allergy Clin Immunol. 2010 Feb; 125(2):328-335.e11.</div>
</div>
</li>
<li class="expanded" reference_id="bib30">
<a href="/pubmed/19169254/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.</a><span class="one_line_source">[Nat Genet.  2009]</span><div class="alt-note">
<div class="authors">Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok PY, Menter A, Lathrop GM, Wise CA, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR, Collaborative Association Study of Psoriasis.</div>
<div class="citation">Nat Genet. 2009 Feb; 41(2):199-204.</div>
</div>
</li>
<li class="expanded" reference_id="bib31">
<a href="/pubmed/20953190/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Genetic Analysis of Psoriasis Consortium &amp; the Wellcome Trust Case Control Consortium 2., Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, Bergboer JG, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Cork MJ, Corvin A, Deloukas P, Dilthey A, Duncanson A, Edkins S, Estivill X, Fitzgerald O, Freeman C, Giardina E, Gray E, Hofer A, Hüffmeier U, Hunt SE, Irvine AD, Jankowski J, Kirby B, Langford C, Lascorz J, Leman J, Leslie S, Mallbris L, Markus HS, Mathew CG, McLean WH, McManus R, Mössner R, Moutsianas L, Naluai AT, Nestle FO, Novelli G, Onoufriadis A, Palmer CN, Perricone C, Pirinen M, Plomin R, Potter SC, Pujol RM, Rautanen A, Riveira-Munoz E, Ryan AW, Salmhofer W, Samuelsson L, Sawcer SJ, Schalkwijk J, Smith CH, Ståhle M, Su Z, Tazi-Ahnini R, Traupe H, Viswanathan AC, Warren RB, Weger W, Wolk K, Wood N, Worthington J, Young HS, Zeeuwen PL, Hayday A, Burden AD, Griffiths CE, Kere J, Reis A, McVean G, Evans DM, Brown MA, Barker JN, Peltonen L, Donnelly P, Trembath RC</div>
<div class="citation">Nat Genet. 2010 Nov; 42(11):985-90.</div>
</div>
</li>
<li class="expanded" reference_id="bib48">
<a href="/pubmed/11133768/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.</a><span class="one_line_source">[Blood.  2001]</span><div class="alt-note">
<div class="authors">Skinnider BF, Elia AJ, Gascoyne RD, Trümper LH, von Bonin F, Kapp U, Patterson B, Snow BE, Mak TW</div>
<div class="citation">Blood. 2001 Jan 1; 97(1):250-5.</div>
</div>
</li>
<li class="expanded" reference_id="bib49">
<a href="/pubmed/12036854/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The role of cytokines in classical Hodgkin lymphoma.</a><span class="one_line_source">[Blood.  2002]</span><div class="alt-note">
<div class="authors">Skinnider BF, Mak TW</div>
<div class="citation">Blood. 2002 Jun 15; 99(12):4283-97.</div>
</div>
</li>
<li class="expanded" reference_id="bib11">
<a href="/pubmed/21037568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, van den Berg A, Olver B, Lloyd A, Dobbins SE, Lightfoot T, van Leeuwen FE, Försti A, Diepstra A, Broeks A, Vijayakrishnan J, Shield L, Lake A, Montgomery D, Roman E, Engert A, von Strandmann EP, Reiners KS, Nolte IM, Smedby KE, Adami HO, Russell NS, Glimelius B, Hamilton-Dutoit S, de Bruin M, Ryder LP, Molin D, Sorensen KM, Chang ET, Taylor M, Cooke R, Hofstra R, Westers H, van Wezel T, van Eijk R, Ashworth A, Rostgaard K, Melbye M, Swerdlow AJ, Houlston RS</div>
<div class="citation">Nat Genet. 2010 Dec; 42(12):1126-1130.</div>
</div>
</li>
<li class="expanded" reference_id="bib50">
<a href="/pubmed/19151747/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation.</a><span class="one_line_source">[Nat Rev Immunol.  2009]</span><div class="alt-note">
<div class="authors">Ho IC, Tai TS, Pai SY</div>
<div class="citation">Nat Rev Immunol. 2009 Feb; 9(2):125-35.</div>
</div>
</li>
<li class="expanded" reference_id="bib51">
<a href="/pubmed/20660789/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells.</a><span class="one_line_source">[Blood.  2010]</span><div class="alt-note">
<div class="authors">Stanelle J, Döring C, Hansmann ML, Küppers R</div>
<div class="citation">Blood. 2010 Nov 18; 116(20):4202-11.</div>
</div>
</li>
<li class="expanded" reference_id="bib52">
<a href="/pubmed/21061265/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes.</a><span class="one_line_source">[Mol Carcinog.  2011]</span><div class="alt-note">
<div class="authors">Monroy CM, Cortes AC, Lopez MS, D'Amelio AM Jr, Etzel CJ, Younes A, Strom SS, El-Zein RA</div>
<div class="citation">Mol Carcinog. 2011 Jan; 50(1):36-46.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p62" name="crb--__p62" rid="__p62">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-49"><ul><li class="expanded" reference_id="bib53">
<a href="/pubmed/18703928/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Curses--winner's and otherwise--in genetic epidemiology.</a><span class="one_line_source">[Epidemiology.  2008]</span><div class="alt-note">
<div class="authors">Kraft P</div>
<div class="citation">Epidemiology. 2008 Sep; 19(5):649-51; discussion 657-8.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p63" name="crb--__p63" rid="__p63">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-50"><ul>
<li class="expanded" reference_id="bib31">
<a href="/pubmed/20953190/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Genetic Analysis of Psoriasis Consortium &amp; the Wellcome Trust Case Control Consortium 2., Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, Bergboer JG, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Cork MJ, Corvin A, Deloukas P, Dilthey A, Duncanson A, Edkins S, Estivill X, Fitzgerald O, Freeman C, Giardina E, Gray E, Hofer A, Hüffmeier U, Hunt SE, Irvine AD, Jankowski J, Kirby B, Langford C, Lascorz J, Leman J, Leslie S, Mallbris L, Markus HS, Mathew CG, McLean WH, McManus R, Mössner R, Moutsianas L, Naluai AT, Nestle FO, Novelli G, Onoufriadis A, Palmer CN, Perricone C, Pirinen M, Plomin R, Potter SC, Pujol RM, Rautanen A, Riveira-Munoz E, Ryan AW, Salmhofer W, Samuelsson L, Sawcer SJ, Schalkwijk J, Smith CH, Ståhle M, Su Z, Tazi-Ahnini R, Traupe H, Viswanathan AC, Warren RB, Weger W, Wolk K, Wood N, Worthington J, Young HS, Zeeuwen PL, Hayday A, Burden AD, Griffiths CE, Kere J, Reis A, McVean G, Evans DM, Brown MA, Barker JN, Peltonen L, Donnelly P, Trembath RC</div>
<div class="citation">Nat Genet. 2010 Nov; 42(11):985-90.</div>
</div>
</li>
<li class="expanded" reference_id="bib28">
<a href="/pubmed/20159242/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions.</a><span class="one_line_source">[J Allergy Clin Immunol.  2010]</span><div class="alt-note">
<div class="authors">Li X, Howard TD, Zheng SL, Haselkorn T, Peters SP, Meyers DA, Bleecker ER</div>
<div class="citation">J Allergy Clin Immunol. 2010 Feb; 125(2):328-335.e11.</div>
</div>
</li>
<li class="expanded" reference_id="bib54">
<a href="/pubmed/15908954/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.</a><span class="one_line_source">[Nat Immunol.  2005]</span><div class="alt-note">
<div class="authors">Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, Lepelletier Y, Greer F, Schomburg L, Fruci D, Niedermann G, van Endert PM</div>
<div class="citation">Nat Immunol. 2005 Jul; 6(7):689-97.</div>
</div>
</li>
<li class="expanded" reference_id="bib55">
<a href="/pubmed/16585582/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines.</a><span class="one_line_source">[J Immunol.  2006]</span><div class="alt-note">
<div class="authors">Fruci D, Ferracuti S, Limongi MZ, Cunsolo V, Giorda E, Fraioli R, Sibilio L, Carroll O, Hattori A, van Endert PM, Giacomini P</div>
<div class="citation">J Immunol. 2006 Apr 15; 176(8):4869-79.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p64" name="crb--__p64" rid="__p64">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-51"><ul>
<li class="expanded" reference_id="bib56">
<a href="/pubmed/16985251/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.</a><span class="one_line_source">[J Natl Cancer Inst.  2006]</span><div class="alt-note">
<div class="authors">Landgren O, Engels EA, Pfeiffer RM, Gridley G, Mellemkjaer L, Olsen JH, Kerstann KF, Wheeler W, Hemminki K, Linet MS, Goldin LR</div>
<div class="citation">J Natl Cancer Inst. 2006 Sep 20; 98(18):1321-30.</div>
</div>
</li>
<li class="expanded" reference_id="bib57">
<a href="/pubmed/16741509/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The risk of lymphoma in patients with psoriasis.</a><span class="one_line_source">[J Invest Dermatol.  2006]</span><div class="alt-note">
<div class="authors">Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB</div>
<div class="citation">J Invest Dermatol. 2006 Oct; 126(10):2194-201.</div>
</div>
</li>
<li class="expanded" reference_id="bib58">
<a href="/pubmed/19845719/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Is there truly a risk of lymphoma from biologic therapies?</a><span class="one_line_source">[Dermatol Ther.  2009]</span><div class="alt-note">
<div class="authors">Dommasch E, Gelfand JM</div>
<div class="citation">Dermatol Ther. 2009 Sep-Oct; 22(5):418-30.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p65" name="crb--__p65" rid="__p65">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-52"><ul><li class="expanded" reference_id="bib11">
<a href="/pubmed/21037568/" ref="reftype=pubmed&amp;article-id=3274508&amp;issue-id=205321&amp;journal-id=753&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, van den Berg A, Olver B, Lloyd A, Dobbins SE, Lightfoot T, van Leeuwen FE, Försti A, Diepstra A, Broeks A, Vijayakrishnan J, Shield L, Lake A, Montgomery D, Roman E, Engert A, von Strandmann EP, Reiners KS, Nolte IM, Smedby KE, Adami HO, Russell NS, Glimelius B, Hamilton-Dutoit S, de Bruin M, Ryder LP, Molin D, Sorensen KM, Chang ET, Taylor M, Cooke R, Hofstra R, Westers H, van Wezel T, van Eijk R, Ashworth A, Rostgaard K, Melbye M, Swerdlow AJ, Houlston RS</div>
<div class="citation">Nat Genet. 2010 Dec; 42(12):1126-1130.</div>
</div>
</li></ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T08:27:13-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal101&amp;ncbi_phid=CE88A7D9DD531ED100000000086E05BE&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3274508%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jnci&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3274508/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>